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Abstract 
 
The consumption of alcohol is a recognised risk factor for the development of oral 
squamous cell carcinoma, an aggressive neoplasm originating from the cells of the oral 
mucosa. Ethanol exerts its carcinogenic effects in the oral cavity through a number of 
secondary pathways. While alcoholic beverages are an accepted risk factor, risk increase 
resulting from chronic exposure to alcohol-containing mouthwashes remains a 
controversial topic with mixed epidemiological and mechanistic evidence. From a 
biological viewpoint, alcohol-containing mouthwash exposure has the potential to induce 
adverse changes in the cells of the oral cavity.  
 
The overall aim of this study is to determine the cellular and molecular changes that occur 
in oral epithelial cells as a result of both acute and chronic repeated exposure to 
physiologic levels of alcohol-containing mouthwashes and their non-alcoholic counterparts. 
To achieve these aims, this thesis has been partitioned into two experimental chapters 
with distinct but intertwined concepts. Normal and dysplastic oral keratinocyte cells 
cultured in a controlled in-vitro environment were utilised as a model to investigate the 
effects of acute and repeated exposures to alcohol-containing mouthwashes and their 
non-alcoholic counterparts.  
 
The first experimental chapter aimed to assess activity in candidate pathways for ethanol-
induced genotoxicity and resultant DNA damage following alcohol-containing and non-
alcoholic mouthwash exposure. Cellular and molecular techniques were employed to 
determine DNA strand breakage, lipid peroxidation levels and CYP2E1 enzyme induction 
and function. Exposure to ethanol, either in solution or within the formulation of a 
mouthwash, was found to induce DNA strand breakage (indicating DNA damage) in oral 
keratinocytes. Greater damage was also observed following alcohol-containing 
mouthwash exposure when compared to non-alcoholic mouthwash exposure. However, 
lipid peroxidation and CYP2E1 activity were not found to correlate with ethanol content, 
suggesting against the involvement of an oxidative damage pathway in ethanol-induced 
genotoxicity. 
 
The second experimental chapter aimed to investigate transcriptomic changes in normal 
and dysplastic oral keratinocytes in response to repeated exposures to alcohol-containing 
and non-alcoholic mouthwash in a physiologic manner. Next-generation sequencing of the 
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whole transcriptome was performed to facilitate differential gene expression analysis and 
pathway enrichment analysis. Dysplastic samples were found to undergo greater 
transcriptomic change (when compared to normal samples) in response to mouthwash 
exposure, particularly in genes associated with xenobiotic metabolism, cell cycle regulation 
and the DNA damage response. The inclusion of ethanol in mouthwash formulations was 
found to have only a minor impact but was responsible for up-regulation of a DNA damage 
response gene in dysplastic samples.  
 
Overall, this study demonstrates that mouthwash exposure, particularly alcohol-containing 
mouthwash, can induce undesirable changes in oral keratinocytes. The response to 
mouthwash exposure was also found to be modulated by the presence of dysplastic 
progression in cells. This thesis outlines these changes, their significance and how both 
future research and clinical usage of alcohol-containing mouthwashes could proceed.
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1.1 Oral Squamous Cell Carcinoma 
 
Oral squamous cell carcinoma (OSCC) is a neoplastic condition that is characterised by 
the malignant transformation of oral keratinocytes. It has been theorised that malignant 
change is brought about by the cells of the oral mucosa (predominantly the highly 
proliferative basal cells) sustaining genetic injury that leads to the development of a 
potentially malignant phenotype. Clonal expansion and growth increases the number of 
these susceptible cells, which may acquire additional genetic changes that increase their 
malignant potential. Thus a progression occurs from normal cells to hyperplasia to varying 
grades of dysplasia and finally an invasive carcinoma that is able to proliferate in the 
absence of stimulation and ignore pro-apoptotic signals.1  
 
OSCC is a significant medical issue, with the annual worldwide incidence estimated to be 
275 000 cases.2 It is the 8th most common malignancy in men and the 13th most common 
malignancy in women on a worldwide basis.3 In countries such as Bangladesh, Sri Lanka, 
India and Pakistan, it is the most common malignancy present in men. It is also believed to 
account for 25% of new cancer cases in these countries.2 In Australia, OSCC represented 
2.9% of all cancers diagnosed and 1.6% of all cancer deaths between 1982 and 2008.4 
The proportion of men suffering from OSCC was originally far higher than that of women, 
however it has declined to a current ratio of 1.5:1.2  
 
There are several major established risk factors for the development of OSCC. These are 
the consumption of alcoholic beverages, tobacco products and betel quid. Each of these 
factors may act separately as an independent risk factor or they can combine 
synergistically.2 In addition to these, there are several other proposed risk factors. 
Considerable evidence exists for an increase in risk associated with infection with 
oncogenic subtypes of human papillomavirus (HPV 6 and 16), poor oral health and a diet 
low in fresh fruits and vegetables.5-7 However, a confounding effect may occur with poor 
diet and poor oral health due to their high coincidence with alcohol intake and smoking.5 
Several other factors have been proposed that have inconsistent epidemiological 
evidence. These include cannabis smoking and nicotine replacement therapy.6 The use of 
alcohol containing mouthwashes is an issue that will be addressed later in this review. 
 
While the chewing of betel quid is a highly prevalent factor (it is estimated that 600 million 
to 1.2 billion people worldwide are regular users), it is largely confined to South East Asia 
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and the Pacific Islands.5 The population attributable risk for OSCC due to consumption of 
alcohol and tobacco in Western countries has been estimated to be as high as 80%.2, 8-11 
A recent pooled analysis of 17 case-control studies from Europe, North America and Latin 
America from the INHANCE (International Head and Neck Cancer Epidemiology) 
consortium analysed the population attributable risk of alcohol and tobacco use from 
11,221 cases of head and neck cancer and 16,168 controls. From this data, the estimated 
population attributable risk of OSCC due to alcohol and tobacco use was found to be 64%. 
This suggests that there are certain unaccounted factors that are contributing to the 
remaining 36% of risk. Of note is the fact that the attributable risk of alcohol and tobacco 
was even lower in women and patients under 45 years when the data was stratified by sex 
and age.12 Interestingly, a study examining oral cancer patients presenting at New York’s 
Sloan Kettering Memorial Centre has found that between 1985 and 2009 there were 
progressive reductions in the prevalence of tobacco and alcohol use.13 Whether or not this 
trend will continue and its possible effects upon the population attributable risk of tobacco 
and alcohol use remains to be seen. 
 
The site distribution of OSCC varies by country and is dependent on the prevalence of risk 
factors. In US and European populations, where smoking and alcohol are the major risk 
factors, 40-50% of OSCCs occur on the tongue. However, in South Asian countries such 
as Sri Lanka where betel quid chewing is heavily prevalent, 40% of OSCCs are found on 
the buccal mucosa.2 
 
OSCC has a poor prognosis, with the 5 year survival rate from the time of diagnosis 
varying from 15-50%. This is due to the fact that patients are generally not diagnosed until 
the carcinoma is well advanced, often with lymphatic spread. This late presentation can be 
attributed to the asymptomatic nature of OSCC.3 Age adjusted death rates from OSCC 
have been estimated to be in the range of 3–4 per 100,000 men and 1.5–2.0 per 100,000 
for women.2 
 
1.2 Alcohol and Oral Cancer – Epidemiological Evidence 
 
In 2002, the number of people worldwide who regularly consume alcoholic beverages was 
estimated to be greater than 1.9 billion people. The average daily consumption was 
approximately 13 g of ethanol (~1 drink).14 Of these consumers, 80 million are expected to 
have diagnosable alcohol abuse disorders.5 Consumption is believed to be rising in many 
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countries, especially in regions of rapid economic growth and among women.15 The World 
Health Organisation’s global burden of disease project assessed the number of deaths 
that could be attributed to alcohol in 2000. They found that the global burden of alcohol 
amounts to 1.8 million deaths per year (approximately 3.2% of all deaths).16  
 
In 2007, the International Agency for Research on Cancer, following a review of the 
available epidemiological evidence, concluded that “alcoholic beverages are carcinogenic 
to humans (Group 1)” and “the occurrence of malignant tumours of the oral cavity, 
pharynx, larynx, oesophagus, liver, colorectum, and female breast is causally related to 
alcohol consumption”. In addition to this, the agency classified the ethanol contained within 
alcoholic beverages as “carcinogenic to humans (Group 1)”.14 Worldwide, approximately 
389 000 cases of cancer can be attributed to chronic alcohol consumption (3.2% of all 
cancers).17 
 
The possibility of alcohol consumption being an independent risk factor for the 
development of OSCC was first explored in 1961.15 Numerous epidemiological studies and 
reviews since that time have investigated the association.8-10, 12, 15, 18-31 By adjusting odds 
ratios for confounding factors and analysing risk factors in non-smokers, these studies 
have indeed confirmed the existence of alcohol consumption as an independent risk factor 
for OSCC. There are several patterns evident. Firstly, increases in risk are strongly 
exposure (drinks per week) dependent, indicating that there is a significant dose-response 
relationship.9, 10, 18-25 While definitions of exposure varied between studies, drinkers with 
‘high’ exposure consistently had higher risk than those with ‘moderate’ exposure. Excess 
risk for ‘high’ exposure varied from 2.2 (>56 drinks/week) to 12.0 (>90 drinks/week).18, 19 
While this is a significant range of odds ratios, all of the mentioned studies consistently 
showed some form of dose-response effect. In 2010, Tramacere et al. published a meta-
analysis of 42 case-control studies, including 17,085 positive cases, examining alcohol 
intake and oral and pharyngeal cancers. Here it was found that the pooled relative risk for 
heavy drinking (≥4 drinks/day) was 5.24 (95% CI, 4.36-6.30), compared to a relative risk 
for light drinking (≤1 drink/day) of 1.21 (95% CI, 1.10-1.33), clearly demonstrating the 
dose-response relationship.32 Secondly, there are mixed results regarding the effects of 
‘moderate’ alcohol intake. Studies have variably reported that there was no excess risk 
generated from moderate intake and that a significant increase in risk occurred.9, 10, 19, 25 
Castellsague et al. concluded that consumption of even 1 drink a day lead to a significant 
increase in risk.25 In their meta-analysis, Tramacere et al. found that 1 drink or less a day 
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conferred a relative risk of 1.21 (95% CI, 1.10-1.33).32 Similarly large meta-analyses by 
Bagnardi et al. and Li et al. concluded that 1 drink or less a day conferred a relative risk of 
1.17 (95% CI, 1.06-1.29) and 1.26 (95% CI, 0.94-1.67) respectively.33, 34 Similarly mixed 
results were found regarding the effect of the duration of alcohol intake (drinking history), 
with several studies indicating an increased risk with increased duration while others 
indicated no effect of duration.8-10, 15, 19, 20, 22, 25, 27, 29, 31, 35-37 With regards to the cessation of 
alcohol intake, the majority of studies found that cessation lead to an immediate reduction 
in risk.20, 25, 37 Castellsague et al. found that there was a significant risk reduction within 3 
years, however it took 14 years to approach the risk of a non-drinker.25 On the other hand, 
Francheschi et al. found that risk actually peaked 7 to 10 years after alcohol cessation and 
that even 10 years after cessation there was no reduction in risk.19 In 2012, a meta-
analysis determined that risk declined after cessation but it took approximately 16 years to 
eliminate any elevated risk.38 Studies have also consistently shown that ethanol 
concentration within beverages acts as an independent risk factor in the development of 
OSCC.8, 21, 23, 25 As the ethanol concentration within a beverage increases, so does risk. 
This was evidenced in the study by Huang et al., who found a 6.4 times increased risk with 
strong spirits compared to other beverages, even after adjusting for total ethanol intake. It 
was suggested that this phenomenon may indicate local effects of ethanol in the oral 
cavity contributing to carcinogenesis.23 
 
One of the challenges associated with gauging the effect of alcoholic beverages in OSCC 
is the frequent presence of smoking as a co-factor. Epidemiological studies are frequently 
affected by low numbers of non-smoking, heavy drinking participants.31 As mentioned 
previously, studies work around this obstacle by adjusting for smoking or concentrating on 
non-smoking drinkers. An example is the pooled analysis by Hashibe et al., which 
managed to examine 1072 cases and 5775 controls who were non-smoking drinkers.28 In 
2012, a meta-analysis by Turati et al. including 18,387 positive cases total also attempted 
to establish alcohol use as an independent risk factor in the development of OSCC by 
examining non-smokers. It was found that in non-smokers use of alcohol conferred a 
relative risk of 1.32 (95% CI, 1.05–1.67) of developing oral and pharyngeal cancer, while 
heavy drinking increased this risk to 2.54 (95% CI, 1.80–3.58).39 
 
As mentioned previously, the smoking of tobacco products acts as an independent risk 
factor for the development of OSCC. In addition to this, studies and reviews examining 
OSCC risk in patients who both smoke and consume alcohol have found that these two 
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factors act synergistically to produce a greater than multiplicative increase in the risk of 
developing OSCC compared to smoking or drinking alone.5, 8-10, 21, 25, 30, 40, 41 A recent 
INHANCE pooled analysis conducted by Hashibe et al. utilising 12828 cases of head and 
neck cancer and 17189 controls confirmed these results, with the study finding a greater 
than multiplicative increase in risk of developing OSCC and pharyngeal SCC when 
smoking and drinking was present.12 It has been theorised that this greater than 
multiplicative effect in the head and neck is brought about by local interaction of tobacco 
and alcohol leading to potentiation of each other’s carcinogenesis.7 Mechanisms include 
increased metabolic activation of procarcinogens due to CYP2E1 induction and increased 
penetration across the oral mucosa. These will be covered in detail in later paragraphs. 
 
1.3 Molecular Mechanisms of the Genotoxicity of Alcohol in Relation to Oral 
Carcinogenesis 
 
While there is a positive correlation between alcohol intake and the development of oral 
cancer, ethanol itself is generally not recognised as a direct carcinogen.15 However, there 
are a number of proposed secondary mechanisms by which ethanol indirectly causes 
genetic damage, thus leading to carcinogenesis.  
 
1.3.1 Acetaldehyde 
 
Acetaldehyde is a highly reactive aldehyde that is produced during the breakdown of 
ethanol. Recently, the International Agency for Research on Cancer decided that there 
was enough evidence to conclude that acetaldehyde associated with the intake of 
alcoholic beverages is a Group 1 carcinogen in humans and is causally related to cancers 
of the oral cavity, pharynx, oesophagus and larynx.42 There are a number of mechanisms 
via which acetaldehyde contributes to genetic damage. 
 
1.3.1.1 Production of Acetaldehyde in the Oral Cavity 
 
Upon entering the body, ethanol is metabolised to acetaldehyde primarily by the enzyme 
alcohol dehydrogenase (ADH). The intermediate is then removed by aldehyde 
dehydrogenase (ALDH). While this process primarily occurs in the liver, it has been shown 
that the required enzymes are expressed in the oral mucosa and gingiva.43 Certain 
polymorphisms in these two enzymes predispose towards a build-up and reduced 
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clearance of acetaldehyde. The gene polymorphism ALDH2*2, found in Asian populations, 
encodes an inactive subunit for the enzyme ALDH2. Heterozygotes who have this allele 
and the competent ALDH2*1 will have less than 10% ALDH function and will record 3 fold 
higher levels of acetaldehyde in the saliva than a competent homozygote on exposure to 
ethanol.17, 41 In a landmark Japanese study, drinking subjects who were heterozygous 
ALDH2*1/2 and thus had increased acetaldehyde retention were found to have a 11 fold 
increased risk for oral cancer compared to homozygotes.44 The increased risk associated 
with this allele combination has been confirmed by meta-analysis.45 It has also been 
shown that drinkers who are heterozygous ALDH2*1/2 have significantly higher levels of 
markers of acetaldehyde related DNA damage in their cells compared to drinkers who are 
homozygous ALDH2*1/1.46 Animal studies conducted with ALDH2-knockout mice have 
shown similar results.47 Compounding this is the discovery that while efficient ADH is 
expressed in the cells of oral cavity and upper aerodigestive tract,  even in competent 
individuals the expression of highly active mitochondrial ALDH2 is very low to negligent.43 
These facts suggest that the local build-up of acetaldehyde in cells and saliva results in 
increased carcinogenetic action in the oral cavity and upper aerodigestive tract, a 
conclusion that others have also come to.43, 48, 49 Another enzyme with significant 
polymorphisms is ADH1B, one of the enzymes responsible for the breakdown of ethanol to 
acetaldehyde. Individuals who are homozygous for the ADH1B*2 allele demonstrate 40 
times more efficient enzyme activity then those who are either homozygous or 
heterozygous for the ADH1B*1 allele.50 Studies investigating the significance of these 
polymorphisms in head and neck cancers found that alcohol drinkers who had the ‘slow’ 
ADH1B (ADH1B*1/*1 or ADH1B*1/*2) were at significantly higher risk compared to those 
with the ‘fast’ ADH1B (ADH1B*2/*2).51-53 While this risk profile seems counterintuitive (as 
acetaldehyde production occurs at a lesser rate), an examination of other sources of 
acetaldehyde production in the oral cavity provides a possible explanation.  
 
In addition to oral mucosal cells, it has been shown that commensal bacteria within the 
saliva (particularly oral streptococci) can produce significant amounts of acetaldehyde by 
utilising bacterial ADH enzymes.48, 54 Homann et al. found that a chlorhexidine mouthrinse 
reduced salivary acetaldehyde from an average of 35.3 µM to 21.5 µM during 
administration of 0.5 g/kg of body weight ethanol (a moderate dose). However, high inter-
individual variation was observed and salivary bacterial counts could not be correlated to 
acetaldehyde production, suggesting that there is high variation between individuals.48 The 
production of acetaldehyde by oral flora has been proposed as the reason why poor oral 
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hygiene has been identified as a risk factor for OSCC.17 This hypothesis is supported by a 
recent study, which found that a stronger association between poor oral hygiene and head 
and neck SCC in patients who had a ‘slow’ ADH1B enzyme compared to the ‘fast’ allele. 
The authors proposed that this association is due to the action of bacterial ADHs eclipsing 
a ‘slow’ mucosal ADH (resulting in the local production of acetaldehyde), as opposed to 
the patients with ‘fast’ alleles where the contribution of bacterial enzymes is less 
significant.55 Commensal oral fungi, in particular species of the genus Candida, have also 
been shown to produce acetaldehyde as a byproduct of the metabolism of ethanol.56 
 
The kinetics of the production of acetaldehyde in the oral cavity has also been 
investigated. Linderborg et al. conducted an in-vivo study that measured salivary 
acetaldehyde at different time points over 10 minutes following a sip of a 40% solution of 
ethanol. On average, the salivary concentration of acetaldehyde peaked at approximately 
180 µM at 2 minutes after the ethanol challenge. This had declined to approximately 75 
µM by the 10 minute point as the acetaldehyde was removed.57 
 
1.3.1.2 DNA Adducts from Acetaldehyde 
 
Exposure of DNA to acetaldehyde leads to the formation of several types of stable adducts 
(a molecule covalently bonded to a DNA base). These additions can interfere with DNA 
synthesis and replication, leading to misincorporations and mutations. N2-ethyl-2’-
deoxyguanosine (N2-ethyl-dG) forms from the reaction of acetaldehyde and 
deoxyguanosine. While it is the most abundant acetaldehyde adduct formed in DNA, it has 
been found to have insignificant mutagenic properties in mammalian cells.58, 59 While N2-
ethyl-dGTP has been found to be readily incorporated into DNA during synthesis, it was 
only incorporated opposite the correct base.60 Perrino et al. also discovered that the 
mammalian DNA polymerase η efficiently bypasses the N2-ethyl-dG lesion during DNA 
replication.61 These facts would account for the low mutagenic potential of this lesion.58, 59 
It has been demonstrated that significant increases in the number of these adducts can be 
seen in oral keratinocytes four to six hours after challenge with ethanol.62 
 
A less prevalent but more sinister adduct than can occur is 1,N2-propano-2’-
deoxyguanosine (1,N2-PdG).41 These adducts are primarily formed from the interaction of 
croton aldehyde (CrA) and DNA.59 CrA is an environmental pollutant and byproduct of lipid 
peroxidation that has mutagenic, genotoxic and carcinogenic properties.58, 63 While 
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originally only shown to occur at extremely high non-physiological levels of acetaldehyde 
exposure, Theruvathu et al. discovered that significant 1,N2-PdG formation could be 
detected at physiological levels of acetaldehyde exposure (100 µM) when physiological 
levels of the ubiquitous intracellular polyamine spermidine were present.59 1,N2-PdG has 
significant effects once adducted to DNA. It leads to the formation of interstrand crosslinks 
and DNA-protein crosslinks and also induces miscoding events with a frequency of up to 
12%.58, 59, 64 As a result, it has been hypothesised that this lesion is predominantly 
responsible for the observed genotoxicity of acetaldehyde.58  
 
1.3.1.3 Chromosomal and DNA Damage by Acetaldehyde 
 
Chromosomal damage in humans can be used as an early biomarker with regards to 
exposure to genotoxic and carcinogenic agents.65 One measure that is utilised is the sister 
chromatid exchange, where two identical sister chromatids exchange genetic information. 
After findings of chromosomal abnormalities in the lymphocytes of alcoholics, it was first 
postulated in 1977 by Obe et al. that it was acetaldehyde and not ethanol that was the 
agent responsible for causing the aberrations. As a result, Obe et al. showed that it was 
possible to induce sister chromatid exchanges in mammalian cells at acetaldehyde 
concentrations as low as 88 µM.66 This has been confirmed since by Helander et al., who 
found that acetaldehyde induced a dose-related frequency of sister chromatid exchanges 
at concentrations varying from 100 µM to 400 µM.67 While sister chromatid exchange may 
be viewed as an overly sensitive marker, it can still be used as a conservative estimator of 
genotoxicity.58   
 
1.3.1.4 Acetaldehyde and DNA Repair 
 
Evidence exists to suggest that acetaldehyde directly interferes with DNA repair 
mechanisms, thereby prolonging genetic damage. O6-methylguanine is a mutagenic DNA 
adduct that may be produced by exogenous carcinogens inducing alkylation of guanine. 
Typically, this adduct is removed by the DNA repair enzyme O6-methylguanine 
transferase. However, this enzyme was found to be inhibited by acetaldehyde at 
concentrations as low as 0.01 µM.68, 69 It is also believed that acetaldehyde binds to and 
alters the action of glutathione, an important intracellular antioxidant.41 
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1.3.2 Induction of CYP2E1 
 
The metabolic breakdown of ethanol can also occur via an alternative pathway termed the 
microsomal ethanol oxidising system (MEOS). This refers to a specific cytochrome P450 
enzyme (CYP2E1) that is induced in response to chronic ethanol intake.70 Induction of 
CYP2E1 can occur within a week if a 40 g/day (~3 drinks) ethanol intake is maintained, 
however this varies between individuals.71 The proportion of ethanol that is oxidised by 
CYP2E1 varies, but has been found to be up to 30% in chronic alcoholics.17 CYP2E1 
induction has been shown to occur in the oral and oesophageal epithelium, indicating that 
the MEOS is active in these epithelial cells.72-75 Farin et al. noted that induction of CYP2E1 
in oral epithelial cells was greater than that in cells from other epithelial surfaces.72 
Induction of CYP2E1 in the oral tissues has several implications regarding carcinogenesis.  
 
In addition to oxidising ethanol, CYP2E1 can participate in the biotransformation of other 
compounds. This includes several exogenous procarcinogens that are converted into their 
active, carcinogenic form by CYP2E1. Examples of these procarcinogens such as N-
nitroso compounds (including nitrosamine) and polycyclic aromatic hydrocarbons occur in 
tobacco smoke.7, 17, 41, 72, 75-77 For example, Farinati et al. found that oesophageal mucosa 
from rats fed on a chronic ethanol diet had a significantly enhanced capacity for 
transformation of the tobacco smoke procarcinogen N-nitrosopyrrolidine compared to 
controls.76 This presents one possible mechanism for the synergistic interaction between 
smoking and ethanol intake with regards to OSCC. 
 
Retinoic acid and its precursor retinol are forms of Vitamin A that have important effects on 
the gene transcription of several regulators of cellular growth and differentiation. CYP2E1 
has been shown break down retinoic acid and retinol and its induction in response to 
ethanol intake has been postulated as the main reason for the depletion of Vitamin A 
isoforms seen in chronic alcohol intake.78 Depletion of retinoic acid has been observed to 
result in the up-regulation of proliferative, anti-apoptotic transcriptional factors such as 
AP1. It is believed that disruption in retinoid metabolism may have a key role in 
carcinogenesis, even in the extrahepatic tissues.41  
 
As a byproduct of the oxidation of ethanol by CYP2E1, a variety of reactive oxygen 
species are produced, leading to the development of a state of oxidative stress.15, 17, 41, 70, 
73, 75 This important mechanism is discussed in further detail below. 
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In the past, investigations have determined that multiple polymorphisms of the gene that 
encodes CYP2E1 exist. One of these, the c2 allele for the RsaI/PstI polymorphism, was 
found to confer a significantly increased risk of developing oral cancer in Asian and mixed 
race subjects.79, 80 This particular allele is associated with increased levels of gene 
transcription and an increased induction of the enzyme by ethanol consumption.81 
 
1.3.3 Oxidative Stress 
 
Oxidative stress primarily refers to an excessive generation of reactive oxygen species 
within a cell. As mentioned above, induction of CYP2E1 as part of the MEOS leads to the 
production of reactive oxygen species. Examples of these agents include hydrogen 
peroxide (which may diffuse across lipid membranes), hydroxyl radicals (which are highly 
reactive), peoxynitrite (which may diffuse within cells) and superoxide.82 Upon interaction 
with DNA, reactive oxygen species can cause multiple types of damage including base 
oxidation and fragmentation, single and double strand breaks, interstrand and intrastrand 
crosslinks and DNA-protein crosslinks.83 Reactive oxygen species also produce a number 
of mutagenic DNA adducts, the most comprehensively studied of which is 8-hydroxy-2'-
deoxyguanosine (8-oxo-dG). This lesion has been shown to induce significant errors 
during DNA replication and is considered mutagenic in humans.70, 82 It has also been 
shown that levels of the adduct are significantly higher in cells isolated from the saliva of 
OSCC patients when compared to controls.84 The various methods by which reactive 
oxygen species damage DNA have implications for carcinogenicity. For example, biopsies 
from patients with OSCC have been shown to demonstrate greater amounts of reactive 
oxygen species and 8-oxo-dG adducts and reduced levels of antioxidant compounds.85, 86 
Oxidative stress also has important implications in cancer-associated fibroblasts, where it 
can drive increased migration and invasion via epithelial-mesenchymal interactions.87 
 
The importance of CYP2E1 in the development of oxidative stress is illustrated in the study 
by Bradford et al., who fed a high ethanol diet to normal mice and mice that were knocked-
out for functional CYP2E1. As a result, it was found that only the normal mice developed 
oxidative DNA adducts.88 Mitochondrial DNA, which is susceptible to damage due to its 
poor repair capacity, may also be affected by reactive oxygen species. Changes in 
mitochondrial DNA have been found to be an important step in carcinogenesis. In addition 
to DNA, reactive oxygen species can also attack other cellular components such as 
12 
 
proteins and lipids.69, 70, 73, 82, 83 The process of lipid peroxidation is particularly important 
and is dealt with in the following paragraph.  
 
1.3.4 Lipid Peroxidation 
 
Lipid peroxidation (LPO) is a common cellular process that occurs when the presence of 
intracellular oxidants (such as reactive oxygen species) leads to the oxidation of 
polyunsaturated fatty acid chains located within the phospholipid bilayer.82 This causes a 
free radical reaction to occur, leading to the breakdown of the lipids and the formation of 
various byproducts including aldehydes such as crotonaldehyde, acrolein, 
malondialdehyde and trans-4-hydroxy-2-nonenal (4-HNE).89 While low levels of lipid 
peroxidation occur in physiological conditions, the process becomes significant during a 
state of excessive oxidative stress as excessive amounts of LPO byproducts are formed.89 
These end products, many of which are reactive electrophiles, react with proteins and 
DNA and induce toxicity and mutagenesis.75, 90, 91 In relation to these effects, high levels of 
LPO products have been found to be tightly associated with carcinogenesis in animal 
models.89 In humans, LPO-related adducts of protein have been demonstrated to occur in 
the oral mucosa of patients with oral precancerous lesions and OSCC.73 A recent study by 
Millonig et al. examined oesophageal biopsies from healthy patients and patients with 
upper aerodigestive tract cancer utilising immunostaining methods. As a result, they found 
a significantly increased number of LPO-related DNA adducts in the patients with cancer.75 
Consistent with the explained relationship between ethanol, CYP2E1 induction and the 
development of oxidative stress, it has been shown that chronic alcohol intake leads to the 
production of increased levels of LPO products.70, 73, 75 In the Millonig et al. study 
mentioned previously, a strong correlation was found between ethanol intake, CYP2E1 
staining and the prevalence of LPO-related DNA adducts.75  
 
Trans-4-hydroxy-2-nonenal (4-HNE) is one of the most abundantly produced aldehyde 
byproducts of LPO. Intracellular levels of 4-HNE vary from 0.1 µM to 3 µM under 
physiological conditions. However, in times of oxidative stress this level can vary from 10 
µM to 5 mM. Due to its molecular structure, 4-HNE can readily react with both DNA and 
cellular proteins.92, 93 These interactions can produce several adverse effects. Firstly, 4-
HNE can directly react with DNA to create several types of DNA adducts. It may form the 
bulky exocyclic DNA adduct 6-(1-hydroxyhexanyl)-8-hydroxy-1,N-2-propano-2'-
deoxyguanosine (4-HNE-dG) with guanosine, an adduct which has been observed to 
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occur in both humans and animals.92, 94 Studies have shown that this adduct forms 
preferentially at sequences in the p53 gene (a tumour suppressor gene) and causes 
transversion mutations in human DNA.95 Interestingly, mutations in the p53 gene are 
critical in oral carcinogenesis and have been reported in approximately 40% of all 
OSCCs.96 4-HNE has also been shown to form an exocyclic variety of adducts termed 
‘ethenobases’, including 1,N2-ethenoguanine (εdG), 1,N6-ethenodeoxyadenosine (εdA) 
and 3,N4-ethenodeoxycytidine (εdC).70, 82, 97 While εdG is the most prevalent adduct 
formed, εdA and εdC have been identified as highly mutagenic in mammalian cells, 
promoting base pair substitutions.41, 70, 82, 98 Secondly, the action of 4-HNE adducting to 
DNA repair enzymes directly interferes with the nucleotide excision repair system. In a 
study by Feng et al., it was shown that treatment of cells with a 100 µM solution of 4-HNE 
reduced base excision repair of benzo[α]pyrene-diol-epoxide (an exogenous carcinogen) 
damage by 50%.89 Thus, 4-HNE exhibits a mutagenic action via its interactions with 
cellular proteins and DNA. 4-HNE also has an important role in oral carcinogenesis, with a 
study by Warnakulasuriya et al., 4-HNE adducts were found in 80% of dysplastic and 
malignant cells from oral biopsies.73 The previously mentioned study by Millonig et al. also 
found that patients with upper aerodigestive tract tumours had a significantly greater 
number of εdA and εdC adducts than healthy patients.75  
  
Malondialdehyde (MDA) is another extensively studied aldehyde byproduct of LPO. While 
MDA is not as abundant as 4-HNE (it reaches concentrations of 20 µM in cells undergoing 
LPO), it is generally regarded as being the most mutagenic byproduct of LPO.90, 99 Similar 
to other aldehydes, MDA reacts with DNA to form several adducts, the most significant of 
which is pyrimido[1,2α]purin-10(3H)-one (M1G).90 M1G has been shown to be highly 
mutagenic in human cells, inducing base-pair substitutions and frame-shift mutations.91, 99 
A study by Fink et al. found that M1G induced a similar spectrum and frequency of 
mutations in Escherichia coli comparable to 1,N2-PdG (an acetaldehyde adduct).100 In a 
similar manner to 4-HNE, MDA can also adduct to DNA repair enzymes, resulting in a 
reduced capacity for nucleotide excision repair. This was shown by Feng et al. in a 2006 
follow up to their previously mentioned 2004 study.99 This is significant as the nucleotide 
excision repair system is responsible for the removal of the MDA-induced M1G adduct. In 
this manner MDA perpetuates its own mutagenicity.90 MDA adducts to DNA and proteins 
have been demonstrated to occur in oral epithelial cells.73, 101 Consistent with the 
relationship between the induction of CYP2E1 and excessive LPO, Warnakulasuriya et al. 
found that increased levels of MDA adducts in oral epithelial cells had a strong correlation 
14 
 
with increased levels of CYP2E1 staining.73 Finally, increased levels of MDA have been 
found to be associated with cancers of the breast, gastric mucosa and cervix and 
significantly higher levels of serum MDA were found in patients with oral cancer when 
compared to controls.91, 102 A study by Sander et al. also found that significantly increased 
levels of MDA adducts were found in biopsies from patients with SCC of the skin 
compared to healthy patients.103 
 
1.3.5 Enhanced Penetration of Carcinogens 
 
There is a growing body of evidence that suggests that ethanol may act to enhance the 
penetration of exogenous carcinogens across the oral mucosa. In 1976, Squier et al. 
showed that the incubation of porcine floor of mouth mucosa with 5% ethanol significantly 
enhanced its permeability to the carcinogen N-Nitrosonornicotine, found in tobacco 
smoke.104 A similar study by Du et al. in 2000 found a similar effect, except the greatest 
increase in penetration occurred at a concentration of 25% to 30% ethanol.105 In both 
studies, a higher concentration of 50% ethanol did not significantly increase permeability of 
the oral mucosa. It was suggested that local concentrations of ethanol this high instead 
have a fixative effect on the tissue instead of a permeating effect.104, 105 One of the 
methodological flaws in these two studies is that the samples were exposed in ethanol for 
up to 24 hours.104, 105 This was accounted for in a 2001 study by Howie et al., who reduced 
the exposure time to 1 hour and still found that penetration of the high molecular weight 
molecule albumin was significantly enhanced at a concentration of 15% ethanol in human 
oral mucosa.106 While other tissues have been tested, this phenomena is most marked in 
the mucosa of the floor of mouth.104, 105 Interestingly, the floor of mouth is regarded as a 
high risk site with regards to OSCC, suggesting a possible relationship.107 Ethanol is a well 
known penetration enhancer in skin, being used in a variety of transdermal delivery 
systems. It has been shown to achieve this effect by removal of barrier lipid from the 
stratum corneum.108 Ganem-Quinitar et al. found a similar loss of barrier lipid occurring in 
porcine palatal mucosa exposed to ethanol. Interestingly, the lipid types that were the most 
reduced were those found predominately in non-keratinised mucosa such as the floor of 
mouth.109 On the other hand, Howie et al. found that lipid fractions within human oral 
mucosa were unchanged following exposure to ethanol. As a result, they suggested that 
ethanol may disrupt lipid architecture, thus opening up a route for the penetration of 
carcinogens.106 Chronic ethanol administration to rats was also found to increase 
penetration of N-Nitrosonornicotine across oral mucosa, suggesting that there may also be 
15 
 
a permeating effect from either chronic local or systemic exposure in addition to the noted 
acute local effects.110 
 
1.3.6 Summary 
 
As demonstrated above, ethanol has a multitude of effects in the oral cavity. The action of 
oral epithelial ADH and bacterial ADHs leads to the production of acetaldehyde. This 
results in the production of mutagenic and genotoxic DNA adducts and chromosomal 
damage. The presence of ethanol also causes activation of the MEOS and the induction of 
CYP2E1 in oral epithelial cells. Effects of this include enhanced activation of 
procarcinogens and the production of reactive oxygen species. These molecules react with 
DNA to form mutagenic adducts and multiple other types of direct DNA damage. Reactive 
oxygen species also interact with cellular lipids to produce lipid peroxidation and its 
associated byproducts. These byproducts, especially 4-HNE and MDA, react with DNA to 
produce mutagenic adducts. Acetaldehyde, 4-HNE and MDA all inhibit selected DNA 
repair enzymes, reducing the capacity of an already stressed repair system. Ethanol 
retained within the oral cavity also enhances the permeability of the oral mucosa to 
exogenous carcinogens. The result of all these mechanisms is a sustained assault on the 
integrity of the DNA, leading to mutations and chromosomal aberrations. A graphical 
representation of these processes is shown in Figure 1.1. 
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Figure 1.1: A graphical representation of the molecular mechanisms of the genotoxicity of 
alcohol in the oral cavity. 
 
 
1.4 Alcohol-Containing Mouthwashes 
 
Ethanol is a key ingredient in a majority of commercially available mouthwashes, acting as 
a solvent, preservative, antiseptic and caustic agent. The concentration it occurs in varies 
between products, but it can be as high as 26% v/v.92 As this concentration exceeds that 
found in certain types of alcoholic beverages, alcohol-containing mouthwashes have come 
under scrutiny regarding any causative link to OSCC. There have been a number of 
epidemiological studies and reviews examining this relationship. In addition to this, a 
number of in-vivo and in-vitro studies have examined the local effects of alcohol-containing 
mouthwashes in the oral cavity. 
 
1.4.1 Alcohol-Containing Mouthwashes and Oral Cancer – Epidemiological Evidence 
 
The possibility of a relationship between mouthwash use and OSCC was first raised 
following a case-series and case-control study in 1979.111 Including this publication, there 
have been 19 case-control studies that have examined mouthwash use in patients with 
OSCC.55, 111-128 There also exist a number of reviews which address the same issue.6, 108, 
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120, 129-134 While this represents a broad base of evidence, the possible carcinogenicity of 
alcohol-containing mouthwashes is still a controversial issue. Overall, the case-control 
studies provide conflicting results regarding the excess risk of OSCC, if any, afforded by 
the use of mouthwashes. Several have reported a significant increase in risk while others 
have reported an insignificant increase in risk, no change in risk or even a reduced risk.55, 
111-128, 135 Similarly, the reviews are divided in their support for and against a relationship.6, 
120, 129-134 
 
One of the reasons for these conflicting results is the great variation in study design 
between the primary case-control studies. The design features of each of these studies 
are depicted in Table 1. In the 18 studies that exist, there is considerable difference with 
regards to the information relating to mouthwash use that was requested from study 
participants. The biggest issue is that only 6 studies (Winn et al. 1991, Winn et al. 2001, 
Cole et al. 2003, Eliot et al. 2013, Chang et al. 2013 and Tsai et al. 2014) specified when 
patients were using alcohol-containing mouthwashes, whereas the rest merely 
investigated the association between ‘mouthwash use’ and OSCC. 55, 116, 119, 120, 126, 127 As 
ethanol has been demonstrated as a carcinogen related to OSCC development, it is 
obviously important that it be specified that exposure to alcohol-containing mouthwash, 
rather than just mouthwash, is being assessed. Reporting on other variables relating to 
mouthwash use was also sporadic, with 15 assessing the frequency of use, 8 assessing 
the history of use, 3 assessing the retention time in the mouth and 3 assessing the 
reasons for mouthwash use.55, 111-128, 135 Studies also varied regarding the site of cancer, 
with most restricting the case definition to SCC of the oral cavity and pharynx, while others 
also included laryngeal sites. This amount of heterogeneity with regards to study design 
means that it is difficult to compare the individual results of each study. 55, 111-128, 135 
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Table 1.1: Characteristics of epidemiological studies examining mouthwash use and 
OSCC. 
Author and Year Specified 
ACM Use 
Frequency 
of Use 
History of 
Use 
Retention 
Time 
Reasons 
for Use 
Weaver et al. 1979  ✓ ✓   
Blot et al. 1983  ✓ ✓ ✓  
Wynder et al. 1983  ✓ ✓   
Young et al. 1986  ✓    
Kabat et al. 1989  ✓ ✓ ✓ ✓ 
Winn et al. 1991 ✓ ✓ ✓  ✓ 
Marshall et al. 1992   ✓   
Talamini et al. 2000  ✓    
Winn et al. 2001 ✓ ✓ ✓ ✓  
Cole et al. 2003 ✓ ✓ ✓  ✓ 
Guha et al. 2007  ✓    
D’Souza et al. 2007  ✓    
Marques et al. 2008  ✓    
Divaris et al. 2010  ✓    
Macfarlane et al. 2010  ✓    
Eliot et al. 2013 ✓ ✓    
Chang et al. 2013 ✓     
Ahrens et al. 2014  ✓    
Tsai et al. 2014 ✓     
 
Another difficulty regarding the quantification of the effect (or not) of alcohol-containing 
mouthwashes on OSCC risk is the high-incidence of their use in patients who also smoke 
and/or drink alcohol.120 As mentioned previously, both smoking and alcohol ingestion are 
independent risk factors in the development of OSCC. It is theorised that the high level of 
overlap between these habits and alcohol-containing mouthwash use may lead to an 
overestimation of the risk imparted by mouthwash use. An example of this is seen in the 
study by Kabat et al., one of the few to assess reasons for patient mouthwash use. It was 
found that female subjects were significantly more likely to use mouthwash to hide the 
odours of tobacco (OR = 3.3, 95% CI 1.24-8.75) and alcohol (OR = 3.25, 95% CI 1.03-
10.3) than food odours (OR = 0.66, 95% CI 0.3-1.43) or dental infections (OR = 0.72, 95% 
CI 0.27-1.94).115 It has also been theorised that underreporting of smoking or alcohol 
usage amongst cases may lead to the overestimation of the effect of alcohol-containing 
mouthwash usage.136 However, it has rightly been pointed out that similar underreporting 
amongst controls would lead to a converse underestimation of risk.137 The effect of these 
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confounding factors can be seen in a 2013 study by Eliot et al., who found that ≥1/daily 
mouthwash use compared to non-users showed a slightly increased risk of developing 
OSCC in heavier drinkers (>2 drinks/day) (OR = 1.14, 95% CI 0.99-1.32) compared to 
non-drinkers (OR = 1.08, 95% CI 0.87-1.34) and ever-smokers (OR = 1.17, 95% CI 1.01-
1.23) compared to never-smokers (OR = 1.10, 95% CI 0.96-1.25).126 In this case, the 
question remains whether the increased risk associated with combined smoking/drinking 
and mouthwash use compared to mouthwash use alone is indicative of a cumulative or 
synergistic effect on risk or due to the presence of smoking and alcohol consumption as 
already established risk factors for the development of OSCC. 
 
In a case-control study in 1983, Wynder et al. identified that the subgroup of non-smoking, 
non-alcohol consuming women who used mouthwash daily had an increased risk of 
developing OSCC (OR = 3.63, 95% CI 1.48-8.92).113 It has been suggested that due to the 
absence of classical risk factors, the non-smoking, non-drinking demographic would be the 
most likely to demonstrate a carcinogenic action of alcohol-containing mouthwash.119 A 
follow-up study limited to women did show a non-significant elevated risk in non-
smokers/non-drinkers who used mouthwash (OR = 1.38, 95% CI 0.42-4.55). However, this 
was hampered by the small population of the subgroup (8 cases, 7 controls).115 Winn et al. 
in 2001 noted a similar non-significant risk increase in the same subgroup (OR = 2.8, 95% 
CI 0.8-9.9), as did Divaris et al.119, 124 On the other hand, Winn et al. in 1991 found that 
odds ratios for non-smoking, non-drinking males and females using mouthwash were 
actually less than those of the general study population.116 
 
Another important aspect that has an impact on the epidemiological evidence related to 
mouthwash use is the prevalence of industry sponsorship. Two of the reviews mentioned 
above, the Gandini et al. meta-analysis, the Shapiro et al. article on the statistical effects of 
underreporting of alcohol and tobacco usage and the Cole et al. review and reanalysis of 
the Winn et al. 1991 dataset all declare some form of industry affiliation.120, 129, 130, 136, 138 
This comes primarily from the pharmaceutical companies Warner and Lambert, Pfizer and 
Johnson and Johnson, who have all held ownership of the mouthwash brand ‘Listerine’. 
The unaffiliated review by Lachenmeier et al. noted that the industry supported studies had 
much more positive conclusions (i.e. no relationship between alcohol-containing 
mouthwashes and OSCC) than other independent reviews and indicated that there may be 
some form of bias occuring.108 
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In 2012, Gandini et al. published a meta-analysis of all known epidemiological studies 
examining the relationship between mouthwash use and oral cancer (totalling 4,484 cases 
and 8,781 controls). After analysis, it was determined that there was no significant 
association between mouthwash use and oral cancer (RR = 1.13; 95% CI 0.95-1.35), no 
significant risk associated with daily use (p = 0.11) and no significant association when it 
was specified that mouthwashes contained alcohol (RR = 1.0; 95% CI 0.39, 2.60).138 
However, it has been questioned whether a meta-analysis with even this number of 
subjects would have enough statistical power to detect a low but significant risk imparted 
by regular use of alcohol containing mouthwashes.139 
 
Overall, the heterogeneity in design and results between epidemiological studies and 
reviews makes it impossible to accurately judge the relationship between use of alcohol-
containing mouthwashes and the development of OSCC. Further consistently designed 
studies with large numbers of participants, stringent examination of all the variables related 
to mouthwash use, specification of ethanol content in mouthwash and detailed control for 
alcohol and tobacco consumption are required before a definitive relationship can be 
established or discredited.  
 
1.4.2 Alcohol-Containing Mouthwashes and Oral Cancer – Mechanistic Evidence 
 
In addition to the epidemiological studies mentioned above, there also exist a number of 
in-vitro and in-vivo studies that investigate the effects of alcohol-containing mouthwashes 
on human cells and in the oral cavity. While consistent epidemiological findings are 
necessary to establish a causal relationship between alcohol-containing mouthwash use 
and the development of OSCC, these studies may provide an insight regarding the local 
effects and possible carcinogenic mechanisms. 
 
As mentioned previously, the production of acetaldehyde from ethanol is regarded by the 
International Agency for Research on Cancer as a carcinogenic process.14 It has also 
been outlined that the metabolism of ethanol to acetaldehyde can occur in the mouth due 
to the presence of ADH in human oral epithelial cells and ADHs produced by commensal 
bacteria. Lachenmeier et al. conducted a trial in healthy human volunteers to quantify the 
amount of acetaldehyde produced in the oral cavity following 30 seconds of exposure to 
13 different alcohol-containing mouthwashes whose alcoholic concentration varied from 
6.8% v/v to 26.8% v/v.140 It was found that while no acetaldehyde was detectable prior to 
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exposure, an average concentration of 52 ± 14 µM (range 11-105 µM) acetaldehyde could 
be detected in the saliva at 2 minutes post-exposure. This value had been reduced to 15 ± 
7 µM (range 0-37 µM) at 10 minutes post-exposure. As is evidenced by the range of 
values, a large amount of inter-individual variation was present.140 The authors noted that 
these were significant findings as it has been proven that formation of the highly mutagenic 
1,N2-PdG adducts can occur at acetaldehyde concentrations as low as 100 µM and sister 
chromatid exchanges can occur in mammalian cells at concentrations as low as 88 µM.59, 
66 Added to this is the recent evaluation by Salaspuro et al. that lead to the conclusion that 
the mutagenic threshold of acetaldehyde in saliva falls between 50 and 150 µM.141 A 
similar study utilising alcohol-containing mouthwashes and human volunteers found 
significantly raised salivary acetaldehyde concentrations ranging from 43.8 to 97.0 µM at 1 
minute post-exposure.142 However, as mentioned previously, Homann et al. found that the 
administration of chlorhexidene mouthrinse significantly reduced local acetaldehyde 
production from ethanol due to its action of reducing oral microbe levels.48 This was also 
demonstrated in a separate trial in which human volunteers rinsed with an alcohol-
containing mouthwash for 30 seconds followed by measuring of salivary acetaldehyde at 
several points. At 2 minutes post-exposure, the essential oil mouthwash resulted in an 
average salivary acetaldehyde concentration of 44.3 µM (range 35.2-63.6 µM) compared 
to an equivalent solution of ethanol which resulted in a concentration of 72.6 µM (range 
46.5-111.2 µM).143 While this is a significantly lower concentration, the alcohol-containing 
mouthwash group still demonstrates individual values that are within Salaspuro’s 
theoretical concentration range of mutagenicity. It should also be noted that this study 
received funding from Johnson and Johnson, the manufacturers of Listerine. Overall, it 
would appear that while the antibacterial properties of alcohol-containing mouthwashes 
reduce the level of acetaldehyde production in the oral cavity (compared to an equivalent 
solution of ethanol), the constituent ethanol of the mouthwash still results in a production of 
acetaldehyde to the level where mutagenic effects may occur. 
 
Another human in-vivo study was conducted by Zamora-Perez et al., who investigated the 
incidence of nuclear abnormalities in exfoliated buccal cells from three groups of 
participants; one group who had used an alcohol-containing mouthwash twice a day for 30 
days, another group who had used an alcohol-free mouthwash and a group who had used 
neither. It was found that compared to the two alcohol-free groups, use of the alcohol-
containing mouthwash resulted in significantly higher numbers of nuclear abnormalities 
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such as micronucleus, binucleated cells and nuclear budding. This is a significant finding 
given that nuclear abnormalities are strong markers of genotoxicity.144  
 
Several other in-vitro studies related to alcohol-containing mouthwashes have been 
conducted. Rodrigues et al. investigated the ability of three different mouthwashes to 
induce genetic mutations using the Drosophila melanogaster Somatic Mutation and 
Recombination Test.145 This test is recognised as being useful in evaluating the 
genotoxicity of environmental agents in humans.146 Rodrigues et al. found that the test 
mouthwash with the highest percentage of ethanol (16.8%) induced a significant number 
of mitotic recombinations. Further investigation determined that it was the ethanol present 
in the mouthwash, not the active ingredient (cetylpyridinium chloride), that was causing the 
genotoxicity. The authors theorised that acetaldehyde was the causative agent in this 
genetic damage.145 Another study used the single-cell gel electrophoresis assay to 
measure the induction of DNA strand breaks in cultured human oral epithelial cells 
following exposure to a dilute solution of an alcohol-containing mouthwash. Significantly 
greater DNA damage was observed when compared to an ethanol-free control group.142 
 
In-vivo studies in animals investigating the effects on the oral mucosa of long-term topical 
exposure to alcohol-containing mouthwashes are non-existent. However, several animal 
studies that utilise pure ethanol in similar concentrations to commercially available 
mouthwashes do exist. Maier et al. investigated the changes that occurred in the oral 
mucosa of rats that were fed a diet containing 6.6% v/v ethanol for 6 months. It was found 
that the floor of mouth, lateral tongue and ventral tongue epithelium of ethanol exposed 
rats had significantly enlarged basal cell nuclei, basal cell hyperplasia, altered epithelial 
stratification and a greater percentage of cells in the S-phase of the cell cycle. It was also 
found that the mean thickness of the floor of mouth mucosa was significantly reduced in 
ethanol exposed rats. The authors concluded that chronic topical exposure to ethanol 
induced both oral mucosal atrophy and hyper-regeneration and this likely resulted in an 
increased susceptibility to carcinogens.147 Another study in rats conducted by Simanowski 
et al. utilising 6.4% v/v ethanol over 5 months found that the proliferation rate of 
oesophageal epithelial cells was significantly increased in rats exposed to ethanol. This is 
a significant finding given that mucosal hyperproliferation is an established risk factor in 
other malignancies such as colorectal carcinoma.148 Muller et al. conducted a similar study 
in rabbits, except utilising higher concentrations of ethanol (20% v/v, 40% v/v and 96% v/v) 
over 12 months. The oral epithelium of ethanol exposed rabbits developed abnormalities 
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such as dyskeratosis, surface keratosis, increased basal layer density and an increased 
number of mitotic figures.149 Given that several problems exist in relating the results of 
these studies to alcohol-containing mouthwash use (increased number of exposures, 
length of exposure, consumption of ethanol etc.), further animal studies are required to 
investigate the local effects of long-term topical exposure to alcohol-containing 
mouthwashes on the oral mucosa.  
 
Overall, mechanistic evidence from these in-vivo and in-vitro studies suggests that the 
metabolism of the ethanol in alcohol-containing mouthwashes can produce a significant 
amount of acetaldehyde in the oral cavity (even up to a level where genetic damage may 
occur). The occurrence of genetic damage after exposure to alcohol-containing 
mouthwashes has been demonstrated in animal models. It is also worth noting the 
remainder of the in-vitro studies investigated the acute toxic effects of short term exposure 
to alcohol-containing mouthwashes, not chronic effects related to repeated exposures.150-
153 However, the production of significant epithelial abnormalities in the oral mucosa of 
animals via chronic topical ethanol exposure has been characterised in a number of 
studies. Greater investigation is required to characterise the events and pathways by 
which genetic damage may occur through chronic exposure to alcohol-containing 
mouthwashes. 
 
It is worth noting however that Lachenmeier et al. (in their review) questioned the 
overarching need for the addition of ethanol to the formulation of antibacterial 
mouthwashes.108 They noted that multiple studies have shown that alcohol-free 
mouthwashes are just as effective and have been shown to have a lower incidence of 
adverse effects than their ethanol containing contemporaries.154-161 An interesting point 
was demonstrated in a study that investigated the production of salivary acetaldehyde 
after rinsing with either an alcohol-containing mouthwash or an alcohol-free variant. It was 
found that use of the alcohol-containing mouthwash resulted in a significantly greater peak 
in salivary acetaldehyde than the alcohol-free version. As the study was run over 2 weeks 
with the same subjects, it was also found that even daily use of an alcohol-containing 
mouthwash induced almost 5-fold greater amounts of salivary acetaldehyde than an 
alcohol-free counterpart.162 
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1.5 Unifying Hypothesis 
 
With regards to undesirable changes in the oral cavity, alcohol induced genotoxicity 
(Section 1.3) meets the epidemiology of alcohol-containing mouthwash exposure (Section 
1.4) to form a theoretical unifying hypothesis utilising the theory of field cancerisation. With 
particular reference to the oral cavity, field cancerisation refers to the theory that exposure 
of environmental carcinogens to the mucosal surface induces undesirable molecular 
changes within the entirety of the mucosa. This results in a cellular “field” that is more 
susceptible to the development of malignant foci at multiple sites.163 Within this model, 
regular topical exposure to alcohol-containing mouthwash could theoretically have several 
effects from a carcinogenic viewpoint (see Figure 1.2). As mentioned previously, a brief 
exposure has already been shown to induce a sharp rise in the level of salivary 
acetaldehyde to a point where there is the potential for mutagenic events to occur. As 
noted, the antibacterial action of alcohol-containing mouthwashes does reduce the 
contribution to salivary acetaldehyde by oral flora, however use of an alcohol-containing 
mouthwash generates significantly higher levels of salivary acetaldehyde compared to a 
non-alcoholic mouthwash, even after two weeks of twice-daily use, after which the oral 
flora would be thoroughly suppressed.162 This demonstrates that even in the relative 
absence of contributing bacteria, ethanol in mouthwashes drives increased salivary 
acetaldehyde. In addition to the direct generation of a carcinogen, ethanol also has indirect 
effects such as increased mucosal permeation, and induction of cytochrome P450 2E1, 
which act to enhance the actions of tobacco related carcinogens. This is likely to be 
relevant to alcohol-containing mouthwash use, as mouthwash users who smoke are at 
greater risk of developing OSCC than non-smoking users.116, 122 These combined effects 
may result in continued mutagenic events within an already sensitised field, promoting 
continued epithelial transformation. The effects of alcoholic beverages in this respect have 
already been seen, as it has recently been shown that continued consumption of alcoholic 
beverages after the development of OSCC significantly increases a patient’s risk of 
developing a second primary OSCC presumably from continued transformation within the 
sensitised field.164 The presence of dysplastic lesions in the oral cavity also presents areas 
of the field that are arguably more sensitive to malignant transformation in response to 
environmental stimuli, given the dysregulation of cellular processes that already exists 
within these cells. While the current epidemiological evidence does not confirm a causative 
relationship between alcohol-containing mouthwash use and OSCC, this unifying 
hypothesis presents a plausible biological model. This was summed up by Johnson et al. 
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in their review, who argued that “absence of evidence is not evidence of absence” with 
regards to the relationship.165  
 
Figure 1.2: Hypothetical model of pathways leading to oral mucosal carcinogenesis 
following alcohol-containing mouthwash use (developed by the candidate in ref 166). 
 
 
1.6 Conclusion 
 
This literature review has examined the role that ingestion of alcohol plays as an 
independent risk factor for the development of OSCC, the established molecular pathways 
through which alcohol may contribute to the development of OSCC and the controversial 
issue of alcohol-containing mouthwashes and OSCC. It was also discussed how these 
aspects, when taken together, can form a theoretical model as to how alcohol-containing 
mouthwash exposure could potentially exert carcinogenic effects within the oral cavity. 
Despite this, the role of alcohol-containing mouthwashes remains unclear due to a 
conflicting body of epidemiological evidence. Further well-designed epidemiological 
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studies are required to investigate the relationship as well as further in-vivo and in-vitro 
studies to investigate the pathways by which oral carcinogenesis may occur. 
 
1.7 Overall Hypothesis and Aims 
 
With regards to this project, our overarching hypothesis that was formulated following a 
comprehensive literature review is that exposure of solutions of alcohol-containing 
mouthwashes will induce greater cellular and molecular changes in oral keratinocytes, 
when compared to their non-alcoholic counterparts. Accordingly, the aim of this 
investigation is to determine the cellular and molecular changes that occur in oral epithelial 
cells as a result of both acute and repeated exposure to physiologic levels of alcohol-
containing mouthwashes (and their non-alcoholic counterparts) in an in-vitro environment.  
 
1.8 Significance of the Aims 
 
As mentioned previously, numerous epidemiological studies that examine the relationship 
between alcohol-containing mouthwash use and oral cancer have been performed. 
However, very few studies have examined the direct cellular and molecular effects of 
alcohol-containing mouthwash use upon oral epithelial cells. Any findings relating these 
changes (particularly those that occur following repeated exposures) will add greatly to the 
already established literature. 
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2.1 Introduction 
 
Oral squamous cell carcinoma (OSCC) is a neoplastic condition that is characterised by 
the malignant transformation of oral keratinocytes. It has been theorised that malignant 
change is brought about by the cells of the oral mucosa sustaining genetic injury that leads 
to the development of a potentially malignant phenotype.1 OSCC is a significant medical 
issue, being the 8th most common malignancy in men and the 13th most common 
malignancy in women on a worldwide basis. In Australia, OSCC represented 2.9% of all 
cancers diagnosed between 1982 and 2008.4 Despite major advances in treatment, it is 
still associated with an approximate 50% 5 year survival rate.3 The major established risk 
factors for developing OSCC are the consumption of alcoholic beverages, tobacco 
products and betel quid (minor risk factors include oncogenic subtypes of human 
papillomavirus and poor oral health).2 As the use of betel quid is primarily confined to 
South-East Asia and the Pacific Islands, in Western societies an estimated 80% of 
population attributable risk for OSCC due to consumption of alcohol and tobacco.2, 8-11 
 
The consumption of alcohol is well established as an independent risk factor for OSCC.8 In 
2010, Tramacere et al. published a meta-analysis of 42 case-control studies, finding that 
heavy drinking (≥4 drinks/day) produced a relative risk of 5.24 (95% CI, 4.36-6.30) 
compared to a non-drinker.32 Alcohol use also demonstrates a dose-response effect, with 
both an increased alcohol intake and beverages of increased alcoholic concentration 
resulting in higher levels of risk.8, 98, 21, 23, 25 This has lead to the supposition that topical 
ethanol exposure has a carcinogenic effect, which is supported by evidence that 
consumption of alcohol is linked to the development of malignancies in the upper 
aerodigestive tract, colon and liver.14, 15   
 
While ethanol itself is generally not recognised as a direct carcinogen, there are a number 
of proposed secondary mechanisms by which ethanol indirectly causes genetic damage, 
thus leading to carcinogenesis.15 Upon entering the body, ethanol is metabolised by the 
enzyme alcohol dehydrogenase (ADH), producing acetaldehyde, which is in turn 
metabolised by aldehyde dehydrogenase (ALDH) to produce harmless acetic acid.43 
Acetaldehyde is a recognised carcinogen that has been shown to produce highly 
mutagenic DNA adducts such as 1,N2-propano-2’-deoxyguanosine (1,N2-PdG) and 
interfere with DNA repair mechanisms.41, 42, 58, 59, 64, 68, 69 Ethanol can also be metabolised 
by the enzyme cytochrome P450 2E1 (CYP2E1), which is induced in response to chronic 
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ethanol intake.70 The presence of both the ADH-ALDH system and CYP2E1 has been 
demonstrated in the oral mucosa.43, 72-75 Increased levels of CYP2E1 has several 
implications for carcinogenesis, including increased activation of pro-carcinogens (such as 
N-nitroso compounds found in tobacco smoke), depletion of retinoic acid and the 
increased production of reactive oxygen species (leading to increased oxidative stress).7, 
41, 70 Increased oxidative stress has a number of harmful effects, including direct DNA 
damage, production of mutagenic 8-hydroxy-2'-deoxyguanosine (8-oxo-dG) DNA adducts 
and the oxidation of cellular lipids (lipid peroxidation).70, 82, 83 Lipid peroxidation results in a 
cascade that produces a number of reactive aldehydes, with malondialdehyde (MDA) and 
4-hydroxynonenal (4-HNE) being the most harmful.89 These two products have both been 
shown to produce mutagenic DNA adducts and interfere with DNA repair.89-91, 97, 99 To 
group these carcinogenic mechanisms together, it has been shown in two separate studies 
that staining of OSCC and esophageal SCC biopsies reveals the presence of 
acetaldehyde adducts, CYP2E1, 4-HNE adducts, MDA adducts.73, 75 There is also 
evidence to show that exposure of mucosa to ethanol enhances the penetration of 
carcinogenic molecules.105, 106 The result of these combined mechanisms is a sustained 
assault on the integrity of DNA, leading to mutations and chromosomal aberrations.   
 
One factor that has come under scrutiny in the past in relation to OSCC risk is the use of 
alcohol-containing mouthwashes (ACMs). Ethanol is a key ingredient in the majority of 
commercially available mouthwashes, acting as a solvent, preservative, antiseptic and 
caustic agent. The concentration it occurs in varies between products, but it can be as high 
as 26% v/v (higher than some alcoholic beverages).92 A number of case-control studies 
and reviews have investigated the epidemiological relationship between ACMs and 
OSCC.6, 108, 111-116, 119, 120, 122-124, 129-135 Overall the literature provides a divided viewpoint, 
with some arguing in favour of a relationship and others arguing against. Reasons for 
these conflicting results include significant variation in study design (including studies 
failing to specify whether mouthwash contained ethanol), high overlap with confounding 
factors and prevalent industry sponsorship of studies. A number of in-vitro and in-vivo 
studies have also investigated ACMs and their effects. Lachenmeier et al. showed that a 
30 second exposure to ACM can generate theoretically genotoxic levels of acetaldehyde in 
saliva while another study found a significantly increased number of nuclear abnormalities 
in exfoliated buccal cells of volunteers who used ACMs twice-daily for a month (when 
compared to controls and a group using non-alcoholic mouthwash).140, 141, 144 Rodrigues et 
al. investigated genotoxicity using a Drosophila melanogaster Somatic Mutation and 
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Recombination Test and found increasing DNA damage with increasing alcohol 
concentration.145 Animal studies testing ACMs are non-existent and equivalent studies with 
ethanol solutions are difficult to compare due to differences in exposure and 
concentration.147, 149 In previously published literature, the authors have proposed a 
unifying hypothesis regarding potential ethanol-induced genotoxicity following ACM 
exposure (see Figure 1.2 in the previous chapter).166 
 
Chapter 1 established that there is a lack of understanding and a lack of published 
literature relating to the cellular and molecular effects of ACMs on human oral 
keratinocytes. This is particularly true regarding the effects of multiple exposures over an 
extended period of time, which is important because manufacturers’ and clinicians’ advice 
can lead to chronic exposure to these products. We identified candidate mechanisms for 
adverse cellular changes in oral keratinocytes following ethanol exposure from a 
comprehensive review of the published literature relating to ethanol-induced genotoxicity in 
human and animal cells and tissues. 
  
The findings of the previous chapter lead to the formulation of a tripartite hypothesis that 
was investigated in this chapter. First, that ethanol within alcohol containing mouthwashes 
induces genotoxic changes in oral keratinocytes through mechanisms previously observed 
in the oral cavity and other tissues. Second, that dysplastic tissue will have an altered 
susceptibility to the genotoxic effects of ethanol contained within ACMs. Third, that non-
alcoholic mouthwashes (NAMs) have a reduced impact on genotoxic changes in normal 
and dysplastic oral keratinocytes through the reduced involvement of our target 
mechanisms. 
 
Accordingly, there were four aims for this chapter. Firstly, to demonstrate ethanol-induced 
genotoxicity in oral epithelial cells in response to ACM exposure. Second, to compare the 
genotoxic potential of ACMs with NAMs in-vitro. Third, to investigate the involvement of the 
proposed candidate mechanisms with regards to the demonstrated ethanol-induced 
genotoxicity in oral keratinocytes. Fourth, to compare the magnitude of genotoxicity in 
normal and dysplasia derived oral epithelial cells. 
 
The aims of this study were investigated in-vitro using 2 non-related keratinocyte cell lines 
that were originally derived from normal and dysplastic oral mucosa. These experiments 
implemented acute and chronic exposures to ACMs and NAMs that were conducted under 
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precisely controlled cell culture conditions carefully selected to avoid the involvement of 
external factors and avoid the excessive quenching of reactive oxygen species. With this 
methodology, controlled experiments to test each of the 3 hypotheses were constructed. 
Key experiment design features included the appropriate pairing of exposure duration to 
measured endpoints, the inclusion of a full range of control exposures, the adoption of 
culture conditions that were compatible with all measurements, and the use of both normal 
and dysplastic mucosa derived cell lines. Measurable endpoints based on the candidate 
mechanisms formed the targets for this investigation. Parameters that were assessed 
include total DNA damage (Comet assay), CYP2E1 activity (p-nitrophenol assay and 
quantitative reverse transcription polymerase chain reaction) and lipid peroxidation (lipid 
peroxidation assay). Two different modes of exposure were performed. Immediately 
following a single short exposure (acute), total DNA damage and lipid peroxidation were 
measured. CYP2E1 activity and induction were measured at the completion of a course of 
short exposures administered twice daily over the course of one week (chronic), given the 
inducible nature of the enzyme.  
 
2.2 Materials and Methods 
 
Cell Culture 
All experiments were conducted using cultured cell monolayers. Two separate cell lines 
were used; hTERT transfection immortalised normal human oral keratinocytes (OKF6) and 
dysplastic oral keratinocytes (DOK). OKF6-TERT2 is a normal oral keratinocyte line 
originally isolated from a 57 year old male that was sourced from the Rheinwald 
Laboratory, Harvard Medical School.167 DOK is a mild to moderate oral epithelial dysplasia 
cell line originally isolated from a 57 year old male that was sourced from the European 
Collection of Cell Cultures (ECACC).168 For the toxicity assay, cells were seeded in 96-well 
plates at a density of 2x104 cells/well. For the Comet assay, cells were seeded in 12-well 
plates at a density of 2x105 cells/well. For the p-nitrophenol assay, quantitative reverse 
transcription polymerase chain reaction (qRT-PCR) and lipid peroxidation assay, cells 
were seeded in 75 cm2 flasks at a density of 2x106 cells/flask. OKF6 cells were cultured in 
keratinocyte serum-free medium (KSFM) containing 25 µg/mL bovine pituitary extract and 
0.2 ng/mL human recombinant epidermal growth factor 1-53, supplemented with CaCl2 
solution to a final concentration of 0.4 mM and with antibiotic-antimycotic. DOK cells were 
cultured in Dulbecco’s Modified Eagle medium (DMEM) containing 2 mM glutamine, 5 
µg/mL hydrocortisone and 10% foetal bovine serum. All tissue culture media and reagents 
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were purchased from Invitrogen (Carlsbad, USA) and Sigma-Aldrich (St. Louis, USA). 
Differences in culture conditions between cell lines were a result of optimisation of 
protocols to produce maximum growth and were unrelated to experimental treatments. All 
samples were cultured to full confluence before the commencement of any assays. 
 
Preparation of the Test Groups 
Test groups consisted of four commercially available mouthwashes, two alcohol-containing 
mouthwashes (ACMs) and two non-alcoholic mouthwashes (NAMs), 1 each from two 
parent brands (‘A’ and ‘B’); A-ACM (Chlorhexidine Gluconate 1.28 mg/mL + Ethanol 96 
mg/mL), A-NAM (Chlorhexidine Gluconate 2 mg/mL), B-ACM (Ethanol 213.03 mg/mL + 
Benzoic Acid 1.5 mg/mL + Thymol 0.64 mg/mL + Eucalyptol 0.92 mg/mL) and B-NAM 
(Sodium Fluoride 0.22 mg/mL + Methyl Salicylate + Thymol + Eucalyptol). Solutions of 4%, 
11.5%, 27% and 40% ethanol in distilled water were also used as test groups in some 
assays. For exposures, test groups were diluted in L-Glutamine negative RPMI media for 
acute exposures (Comet assay and lipid peroxidation assay) and 1:1 DMEM / Nutrient 
Mixture F12 containing 10% fetal bovine serum and 1% antibiotic-antimycotic for chronic 
exposures (p-nitrophenol assay and qRT-PCR). Control groups consisted of plain RPMI 
media (negative control) and 0.3% hydrogen peroxide in RPMI (positive control), with the 
exception of the lipid peroxidation assay (PBS and 500 µM hydrogen peroxide in PBS 
respectively). 
 
Toxicity Assay 
In order to determine an acceptable test exposure for the study, a toxicity study was 
performed in 96-well plates. Two exposure regimens were trialled; a one-time exposure of 
5 minutes (an acute exposure) and repeated exposures twice daily for 10 minutes for 1 
week total (a chronic exposure). The methods and results for these trials are detailed in 
the Appendix. Analysis of data determined that an acute exposure of 1% and a chronic 
exposure of 0.5% fulfilled the experimental requirements of the study. 
 
Single Cell Gel Electrophoresis Assay 
The single cell gel electrophoresis assay (Comet assay) used was based on a modified 
Speit and Hartmann protocol.169 For each mouthwash, three different test groups were 
produced. The first test group (Original) consisted of unaltered mouthwash. The second 
test group (Water) was produced by drying down the mouthwash in a centrifugal 
evaporator and reconstituting it to its original weight with distilled water, thus producing 
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ethanol negative test groups. As drying down would remove any other volatile compounds, 
a third test group (Ethanol) was produced by taking the dried down mouthwash and 
reconstituting it to its original weight with an appropriate solution of ethanol in distilled 
water (A-ACM and A-NAM – 96 mg/mL, B-ACM and B-NAM – 0.27 mL/mL). In order to dry 
down the mouthwash, the samples were run in a centrifugal evaporator at 60°C for 90 min. 
Each of the test groups was diluted in RPMI media to a final concentration of 1% and 1000 
µL of each was exposed to the cells for 5 min at 37°C. Following exposure, the wells were 
washed twice with 1xPBS (Mg+ and Ca+ free). Cells were trypsinised and collected using 
TrypLE Express and 10% fetal bovine serum in 1xPBS into Eppendorf tubes to yield 
approximately 1x106 cells/mL. 10 µL of each tube (approximately 1x104 cells) was then 
placed into a new Eppendorf tube and mixed with 120 µL of 0.5% low melting point (LMP) 
agarose at 37°C and layered onto slides precoated with 1.5% regular agarose. Cover slips 
were placed over the LMP agarose mixture then removed upon brief setting at 4°C. The 
prepared slides were immersed into cold, freshly made lysing solution (2.5 M NaCl, 100 
mM EDTA, 10 mM Tris-HCl buffer (pH 10), 1% sodium sarcosinate with 1% Triton X-100 
and 10% dimethyl sulfoxide) at 4°C for 1 hour. Slides were then gently removed from 
lysing solution and placed in a gel box immersed in alkaline buffer (pH 13) at 4°C. Slides 
were allowed to sit for 20 min to allow unwinding of the DNA. Slides were then 
electrophoresed for 20 min at 15V/300mA (approximately 1.0V/cm). Following 
electrophoresis, slides were washed thoroughly twice with drops of neutralisation buffer 
(0.4 M Tris-HCl pH 7.5), left to sit for at least 5 min, drained, rinsed carefully with distilled 
water and dried. In order to minimize extraneous DNA damage from ambient light, steps 
were performed with reduced illumination. To stain, 40 µL of 20 µg/mL ethidium bromide 
staining solution was applied and covered with a coverslip. Slides were stained one by one 
then evaluated immediately. Between 50 and 100 comets per slide were randomly 
selected and captured utilising a Zeiss Axiovision M1 fluorescence microscope (Carl Zeiss 
AG, Jena, Germany) at x400 magnification (x10 ocular, x40 objective). Comets were 
evaluated using the commercially available software CometScore™ (TriTek Corporation, 
Sumerduck, USA). Percentage tail DNA migration was used as the statistic of DNA 
damage evaluation.  
 
Lipid Peroxidation Assay 
The lipid peroxidation assay to measure total MDA formation was adapted from a 
thiobarbituric acid reactive substances (TBARS) assay outlined by Nagababu et al.170 
Each of the test groups was diluted in PBS to a final concentration of 5%. Cells were 
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trypsinised and collected using TrypLE Express and L-Glutamine negative RPMI media 
with added 10% fetal bovine serum to yield approximately 5x106 cells. 1000 µL of each 
control and test group was exposed to the cells for 1 hr at 37°C. After centrifugation and 
resuspension in 1000 μL of PBS, cells were sonicated for 1 min in an ultrasonic water bath 
(Citizen Scale, Mumbai, India). 1000 μL of 0.67% w/v thiobarbituric acid (TBA), 500 μL of 
20% w/v trichloroacetic acid and 25 μL of 0.2% w/v butylated hydroxytoluene were added 
to the resulting lysate, vortexed and incubated at 95°C for 45 min in a water bath. 
Following incubation, the reactions were cooled on ice for 5 min. The coloured TBA-MDA 
complexes were extracted into 1000 μL of n-butanol by mixing and centrifugation at 3,500 
g for 5 min at 0°C. 200 μL of the coloured organic layer was transferred in triplicate to a 
96-well plate and the absorbance at 525 nm was measured on a Paradigm Detection 
Platform (Beckman Coulter, Brea, USA). 
 
p-Nitrophenol Assay for CYP2E1 Activity 
Cell monolayer cultures were exposed to test groups and controls for 10 minutes, twice 
daily for 7 days. Test groups were diluted to a final concentration of 0.5% in 1:1 DMEM / 
Nutrient Mixture F12 containing 10% fetal bovine serum and 1% antibiotic-antimycotic. 
Monolayers were maintained in fresh 1:1 DMEM / Nutrient Mixture F12 containing 10% 
fetal bovine serum and 1% antibiotic-antimycotic in between exposures. Following final 
exposure, cells were trypsinised and collected using TrypLE Express and fresh incubation 
media. The cell pellet was resuspended in 1.5 mL of ice-cold lysing buffer (0.25 M 
potassium phosphate, 0.15 M potassium chloride, 0.25M sucrose, 1 mm EDTA pH 7.5) 
and homogenised by bead beating (Biospec Products, Bartlesville, USA) for 5 secs. The 
resulting homogenate was centrifuged at 10,000 g for 15 min at 4°C. The supernatant was 
then centrifuged at 100,000 g for 1 hr at 4°C. The supernatant was discarded and the 
resulting microsomal pellet resuspended in 100 uL of ice-cold assay buffer (50mM 
potassium phosphate, pH 7.4). The protein concentration was then determined using a 
BCA Protein Assay Kit (Thermo Scientific, Rockford, USA). Mouse hepatic microsomes 
extracted from fresh mouse liver by the same process were used as a positive control. 
CYP2E1 activity was determined using the high performance liquid chromatography 
detection of CYP2E1 catalysed transformation of p-nitrophenol to 4-nitrocatechol, as 
described by El Barbry et al. with modifications.171 The assay mixture contained assay 
buffer, 100 µM p-nitrophenol, 0.5 mg/mL NADP+, 10 mM D-glucose-6-phosphate, 10 mM 
magnesium chloride and 1 U glucose-6-phosphate dehydrogenase. The reaction was 
initiated by the addition of 200 µg of extracted microsomal protein and incubated at 37°C 
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for 30 min. The reaction was stopped by the addition of 20% trichloroacetic acid and 
centrifuged at 10,000 g for 5 min. Samples were analysed on a Waters 2695 Separation 
Module with 486 Turnable UV absorbance detector (Waters Corporation, Milford, USA) 
and resolved on a 150 mm x 4.6mm Gemini C18 column with guard cartridge 
(Phenomenex, Lane Cove, Australia) under isocratic conditions (60:40 10% acetonitrile + 
0.1% trifluoracetic acid : 90% acetonitrile + 0.1% trifluoracetic acid) at a flow rate of 1 
mL/min. The elution of 4-nitrocatechol and 4-nitrophenol were monitored at 360 nm. 
Standards of 4-nitrocatechol ranging from 200 nM to 1 mM in 60% acetonitrile were 
utilised for comparison.  
 
Semi-Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction for 
CYP2E1 mRNA expression 
Cell monolayer cultures were exposed to test groups and controls for 10 minutes, twice 
daily for 7 days. Test groups were diluted to a final concentration of 0.5% in 1:1 DMEM / 
Nutrient Mixture F12 containing 10% fetal bovine serum and 1% antibiotic-antimycotic. 
Monolayers were maintained in fresh 1:1 DMEM / Nutrient Mixture F12 containing 10% 
fetal bovine serum and 1% antibiotic-antimycotic in between exposures. Following final 
exposure, cells were trypsinised and collected using TrypLE Express and fresh incubation 
media. RNA was extracted using the AllPrep DNA/RNA/miRNA Universal Kit (Qiagen, 
Venlo, Netherlands) according to the manufacturer’s instructions. For each sample, the 
cell pellet was homogenised in the provided buffer (containing β-mercaptoethanol), 
transferred to a DNA spin column and centrifuged at 18,000 g for 30 sec. While the DNA-
containing spin column was stored at 4°C, Proteinase K and absolute ethanol was 
incubated at room temperature for 10 min and followed by the addition of additional 
absolute ethanol. The sample was transferred to a RNA spin column and centrifuged at 
18,000 g for 15 sec. This was followed by the addition of buffer, centrifugation at 18,000 g 
and discarding of flow-through. The column was then incubated with DNAse I at room 
temperature for 15 min. This was followed by the addition of buffer, centrifugation at 
18,000 g and the recentrifugation of the flow-through. The washing step was repeated with 
buffer followed by ethanol. After drying of the spin column membrane, RNA was eluted in 
80 µL RNAse-free water by centrifugation at 8000 g for 1 min. The quality and quantity of 
RNA was assayed utilising a Nanodrop 1000 spectrophotometer (Thermo Scientific, 
Waltham, USA). cDNA was synthesised using a SuperScript® III Reverse Transcriptase kit 
(Invitrogen). A reaction mixture consisting of 5 µg of isolated RNA, 50 ng/µL random 
hexamers, 10 mM dNTP mix and RNAse-free water was heated at 65°C for 5 min and 
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placed on ice for at least 1 min. 5X first strand buffer, 0.1M dithiothreitol, 40 U/µL RNAse 
Out and 200 U/µL SuperScript III reverse transcriptase were added. This was followed by 
incubation at room temperature for 5 mins, 50°C for 45 mins and 70°C for 15 mins. Real-
time reverse transcription polymerase chain reaction was used to amplify three 
sequences; RPL13A (the highly expressed housekeeping gene), CYP2E1 Intron and 
CYP2E1 Exon 8. Primer pairs used were: RPL13A, forward 5’-ATG GTC GAG GCC ATC 
TCC TG-3’, reverse 5’-TGA TGC CTT CAC AGC GTA CG-3’; CYP2E1 Exon 8, forward 5’-
GAT ACC TCA TCC CCA AGG GC-3’, reverse 5’-ACA CAC TCG TTT TCC TGT GG-3’. 
RT-PCR was performed with a StepOnePlus Real-Time PCR System (Applied 
Biosystems, Life Technologies, Carlsbad, USA). Optimised reactions (15 µl) contained 
8.25 µl SYBR® Green PCR Master Mix (Invitrogen), 0.33 µl forward and reverse primers 
at 10 µM, 150 ng of diluted cDNA and made up to volume with UltraPure water. 
Thermocycling: 95°C for 10 min followed by 30 cycles of 95°C for 15 sec and 60°C for 1 
min. The comparative ΔΔCt method was used to quantify target mRNA relative to the 
endogenous reference RPL13A. 
 
Statistical Analysis 
All results are presented as mean ± standard deviation or median with 95% CI where 
noted. Values were analysed with Bartlett’s Test and found to be heteroscedastic. 
Statistical significance of differences between groups was determined through Kruskal-
Wallis one-way analysis of variance with Dunn’s Multiple Comparison Test to investigate 
individual pairings (GraphPad Prism 6.0, GraphPad, USA). 
 
2.3 Results 
 
Single Cell Gel Electrophoresis Assay (Comet Assay) 
DNA strand breaks in response to exposure to control and test groups were measured in 
normal oral keratinocytes (OKF6) and dysplastic oral keratinocytes (DOK) using the single 
cell gel electrophoresis assay (Comet assay). Data from two discrete experiments was 
pooled for analysis. The representative photomicrographs in Figure 2.1 show examples of 
‘comets’ produced by individual OKF6 cells as a result of the assay and give examples of 
percentage tail DNA migration (the variable being measured). The mean percentage tail 
DNA migration along with standard deviation for each test group from the OKF6 cell line 
and the DOK cell line are listed in Table 2.1. Intra-assay and inter-assay coefficients of 
variation (CVs) were calculated for positive and negative control groups. OKF6 control 
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groups had intra-assay CVs of 62.68% and 3.2% and inter-assay CVs of 37.45% and 
1.91% for negative and positive control groups respectively. For DOK control groups, intra-
assay CVs of 36.46% and 2.47% and inter-assay CVs of 6.19% and 1.27% for negative 
and positive control groups were seen. Percentage tail DNA migration values for positive 
and negative controls for both cell lines are presented in Figure 2.2. Box and whisker plots 
of control and test groups are depicted in Figures 2.2 – 2.7, showing median, 1st and 3rd 
quartiles, 2nd and 98th percentiles and outliers. 
 
In OKF6 cells (Figures 2.3 – 2.4), a significant difference in DNA migration was found 
between the “Original” test group and the “Water” test group in the ACMs (p < 0.001; 
Kruskal-Wallis with Dunn’s) but not in the NAMs. A significant difference was also seen 
between the “Original” groups of the ACMs and NAMs within parent brand (A-ACM vs. A-
NAM and B-ACM vs. B-NAM, p < 0.001; Kruskal-Wallis with Dunn’s). Finally, a significant 
difference between the test groups “Original” and “Ethanol” was not found for A-ACM and 
B-ACM but was for A-NAM and B-NAM (p < 0.001; Kruskal-Wallis with Dunn’s). Exposure 
to pure ethanol solutions (Figure 2.7) showed significant increases in DNA migration from 
11.5%, 27% and 40% solutions (p < 0.001; Kruskal-Wallis with Dunn’s) but not a 4% 
solution when compared to negative control. In DOK cells (Figures 2.5 – 2.6), once again a 
significant difference in DNA migration was found between the “Original” test group and 
the “Water” test group in the ACMs (p < 0.001; Kruskal-Wallis with Dunn’s) but not in the 
NAMs. A similar result to the OKF6 cell line was also seen in the comparisons of “Original” 
formulations of ACMs and NAMs within parent brand (A-ACM vs. A-NAM and B-ACM vs. 
B-NAM, p < 0.001; Kruskal-Wallis with Dunn’s). In the comparison of “Original” and 
“Ethanol” test groups, A-NAM and B-NAM showed significant differences (p < 0.001; 
Kruskal-Wallis with Dunn’s), as well as B-ACM (p = 0.0462; Kruskal-Wallis with Dunn’s). 
Once again, 11.5%, 27% and 40% solutions of ethanol (Figure 2.7) showed significant 
increases in DNA migration compared to control (p < 0.001; Kruskal-Wallis with Dunn’s). 
Comparison by Mann-Whitney test of the median DNA migration of negative control 
exposures (RPMI) of both tested cell lines showed significantly (p < 0.001; Kruskal-Wallis 
with Dunn’s) increased migration in the DOK cell line (19.23% ± 6.47) compared to the 
OKF6 cell line (8.18% ± 6.13).  
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Figure 2.1: Representative photomicrographs of OKF6 cell ‘comets’ from a single cell gel 
electrophoresis assay (Comet assay) demonstrating increasing amounts of tail DNA 
migration. Examples of DNA damage are depicted: A) ~10% tail DNA migration, B) ~30% 
tail DNA migration, C) ~60% tail DNA migration, D) ~95% tail DNA migration. Original 
magnification: x40 objective. 
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Table 2.1: Mean percentage tail DNA migration in OKF6 and DOK cells following exposure 
to test groups derived from A-ACM, A-NAM, B-ACM and B-NAM. Cells were exposed to a 
1% solution of test groups along with plain RPMI (negative control) and 0.3% H2O2 
(positive control). Results are expressed as mean ± standard deviation. 
OKF6  DOK 
Test Group 
% Tail DNA 
Migration 
Test Group 
% Tail DNA 
Migration 
RPMI 9.69 ± 6.43 RPMI 19.52 ± 7.1 
0.3% H2O2 94.88 ± 3.6 0.3% H2O2 95.76 ± 2.62 
A-ACM Original 49.01 ± 19.44 A-ACM Original 64.2 ± 10.9 
A-ACM Water 24.77 ± 16.34 A-ACM Water 32.2 ± 13.34 
A-ACM Ethanol 53.61 ± 17.59 A-ACM Ethanol 61.67 ± 11.59 
A-NAM Original 24.79 ± 18.83 A-NAM Original 37.15 ± 15.13 
A-NAM Water 24 ± 17.33 A-NAM Water 36.21 ± 13.54 
A-NAM Ethanol 45.8 ± 16.67 A-NAM Ethanol 56.99 ± 13.89 
B-ACM Original 62.81 ± 16.74 B-ACM Original 71.25 ± 8.04 
B-ACM Water 26.06 ± 18.93 B-ACM Water 36.9 ± 13.57 
B-ACM Ethanol 52.45 ± 15.19 B-ACM Ethanol 60.19 ± 11.13 
B-NAM Original 29.05 ± 16.39 B-NAM Original 38.24 ± 15.26 
B-NAM Water 24.33 ± 14.69 B-NAM Water 32.98 ± 15.34 
B-NAM Ethanol 56.84 ± 13.98 B-NAM Ethanol 54.83 ± 14.27 
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Figure 2.2: DNA damage in OKF6 and DOK cells exposed to plain RPMI (negative control) 
and 0.3% H2O2 (positive control). Results are expressed as box plot of percentage tail 
DNA migration. 
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Figure 2.3: DNA damage in OKF6 cells exposed to test groups derived from A-ACM and 
A-NAM. Cells were exposed to a 1% solution of test groups. Results are expressed as box 
plot of percentage tail DNA migration (*** = p < 0.001; Kruskal-Wallis with Dunn’s). 
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Figure 2.4: DNA damage in OKF6 cells exposed to test groups derived from B-ACM and 
B-NAM. Cells were exposed to a 1% solution of test groups. Results are expressed as box 
plot of percentage tail DNA migration (*** = p < 0.001; Kruskal-Wallis with Dunn’s). 
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Figure 2.5: DNA damage in DOK cells exposed to test groups derived from A-ACM and A-
NAM. Cells were exposed to a 1% solution of test groups. Results are expressed as box 
plot of percentage tail DNA migration (*** = p < 0.001; Kruskal-Wallis with Dunn’s). 
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Figure 2.6: DNA damage in DOK cells exposed to test groups derived from B-ACM and B-
NAM. Cells were exposed to a 1% solution of test groups. Results are expressed as box 
plot of percentage tail DNA migration (*** = p < 0.001; Kruskal-Wallis with Dunn’s). 
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Figure 2.7: DNA damage in OKF6 and DOK cells exposed to test groups derived from 
absolute ethanol. Cells were exposed to a 1% solution of test groups. Results are 
expressed as box plot of percentage tail DNA migration. 
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Lipid Peroxidation Assay 
Induction of lipid peroxidation in normal oral keratinocytes (OKF6) and dysplastic oral 
keratinocytes (DOK) following exposure to control and test groups was measured using an 
assay based on the production of thiobarbituric acid reactive substances (TBARS). Data 
was pooled from two biological replicates, each measured in triplicate (n=2). The 
production of TBARS relative to the negative control group (PBS) is shown for both OKF6 
and DOK samples in Figure 2.9 and Figure 2.10 respectively. 500 µM (0.0015%) H2O2 in 
PBS was utilised as a positive control. Results are expressed in the form of absorbance at 
525 nm relative to the negative control group (RA525). 
 
In OKF6 cells (Figure 2.8), greater induction of lipid peroxidation was noted in 3 of the test 
groups when compared to the negative control group. A-ACM demonstrated a small 
relative increase (RA525 = 1.29, 95% CI 1.10-1.77), while larger relative increases were 
shown by A-NAM (RA525 = 1.78, 95% CI 0.85-3.30) and B-NAM (RA525 = 1.81, 95% CI 
1.40-2.90). The increase associated with exposure to the B-NAM group was statistically 
significant (p < 0.05; Kruskal-Wallis with Dunn’s). A high standard deviation for the A-NAM 
group indicates a greater spread of values, which is confirmed by comparing the 
coefficient of variation of the group to that of the OKF6 population (cv = 0.56 vs cv = 0.3). In 
DOK cells (Figure 2.9), a greater induction of lipid peroxidation was noted in all 4 test 
groups (relative to the negative control group). A-ACM (RA525 = 1.36, 95% CI 1.28-1.47) 
and B-ACM (RA525 = 1.31, 95% CI 0.97-1.67) both demonstrated lesser increases 
compared to A-NAM (RA525 = 1.83, 95% CI 1.45-2.24) and B-NAM (RA525 = 1.82, 95% CI 
1.68-1.91). Both increases associated with the NAM groups were found to be statistically 
significant (p < 0.05; Kruskal-Wallis with Dunn’s). Overall, NAM groups (A-NAM and B-
NAM) induced greater lipid peroxidation than their ACM counterparts (A-ACM and B-ACM) 
in both the OKF6 and DOK cell lines. 
 
When comparing the responses of the two cell lines with each other, it was found that 
DOK samples reported absorbance values at 525 nm that were on average over 6-fold 
greater than the corresponding OKF6 samples exposed to the same test conditions. 
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Figure 2.8: Production of TBARS in OKF6 cells exposed to controls and 5% solution of test 
groups for 1 hr. Expressed as median absorbance relative to negative control (PBS) with 
95% CI (* = p < 0.05; Kruskal-Wallis with Dunn’s).   
 
 
Figure 2.9: Production of TBARS in DOK cells exposed to controls and 5% solution of test 
groups for 1 hr. Expressed as median absorbance relative to negative control (PBS) with 
95% CI (* = p < 0.05; Kruskal-Wallis with Dunn’s). 
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two runs, with two measurements taken for each sample in each run. The chromatograms 
for each of the samples are shown in Figures 2.10 and 2.11. Standards of 4-nitrocatechol 
ranging from 200 nM to 1 mM were used to produce a standard curve (Figure 2.12). 
Preliminary assays established the limit of detection of 4-nitrocatechol to be 34.44 ng/mL, 
based on a 3:1 signal to noise ratio. The retention time of 4-nitrocatechol was 3 min 38 sec 
for the OKF6 run and 3 min 21 sec for the DOK run. The peak elution of the substrate p-
nitrophenol occurred at 5 min 5 sec for the OKF6 run and 4 min 30 sec for the DOK run. 4-
nitrocatechol production for each of the samples was calculated from peak absorbance 
and is shown in Table 2.2. 
 
Microsomes isolated from both OKF6 and DOK cells exposed to negative control and test 
groups both showed no detectable CYP2E1 enzyme function. This suggests either a 
complete lack of CYP2E1 activity in microsomes isolated from OKF6 and DOK cells or 
activity that is below the aforementioned detection limit of the assay. However, CYP2E1 
activity was recorded from the positive control groups (mouse hepatic microsomes), 
producing 754.36 ± 0.67 ng/mL and 1152.11 ± 4.22 ng/mL of 4-nitrocatechol in the OKF6 
and DOK runs respectively. 
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Figure 2.10: Chromatograms showing the elution of 4-nitrocatechol (4-NC) and p-
nitrophenol (p-NP) after incubation of p-nitrophenol with microsomes derived from OKF6 
cells treated with control and test groups. 
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Figure 2.11: Chromatograms showing the elution of 4-nitrocatechol (4-NC) and p-
nitrophenol (p-NP) after incubation of p-nitrophenol with microsomes derived from DOK 
cells treated with control and test groups. 
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Figure 2.12: Standard curve of absorbance at 360 nm (A360) of 4-nitrocatechol standards 
ranging from 200 nM to 1 mM with logarithmic transformation.  
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Table 2.2: 4-nitrocatechol production in microsomes isolated from OKF6 and DOK cells 
exposed to test and control groups. Calculated from peak absorbance. Expressed as 
mean ± standard deviation. 
Test Group Peak Absorbance (360nm) 4-Nitrocatechol (ng/mL) 
OKF6 
Negative Control 0 n/a 
Positive Control 14104.5 ± 12.02 754.36 ± 0.67 
A-ACM 0 n/a 
A-NAM 0 n/a 
B-ACM 0 n/a 
B-NAM 0 n/a 
11.5% EtOH 0 n/a 
27% EtOH 0 n/a 
DOK 
Negative Control 0 n/a 
Positive Control 21221 ± 74.95 1152.11 ± 4.22 
A-ACM 0 n/a 
A-NAM 0 n/a 
B-ACM 0 n/a 
B-NAM 0 n/a 
11.5% EtOH 0 n/a 
27% EtOH 0 n/a 
   
55 
 
Semi-Quantitative Real-Time Reverse Transcription Polymerase Chain Reaction for 
CYP2E1 mRNA expression 
Semi-quantitative real-time PCR analysis of CYP2E1 expression was conducted on 
normal (OKF6) and dysplastic (DOK) oral keratinocytes subjected to repeated exposures 
to solutions of alcohol-containing and non-alcoholic mouthwashes and ethanol controls. 
Reported values were determined from triplicate assays within one discrete run (n=3). The 
relative abundance of CYP2E1 transcripts in relation to the negative control group (RPMI) 
for both cell lines are shown in Figure 2.12.  
 
In OKF6 cells, no increases in CYP2E1 expression relative to negative controls were 
observed in cells exposed to test groups. In fact, both the 11.5% ethanol and 27% ethanol 
groups displayed a reduced relative expression (RQ = 0.76 ± 0.03 and RQ = 0.68 ± 0.02 
respectively), though this difference was not statistically significant. In DOK cells, non-
significant increases in relative expression were seen in both the 11.5% ethanol (RQ = 
2.11 ± 0.08) and 27% ethanol groups (RQ = 2.07 ± 0.05). A dose-response effect was not 
observed between these two groups, nor were any increases in CYP2E1 expression 
associated with exposure to the other test groups containing ethanol (A-ACM and B-ACM). 
In both OKF6 and DOK cell lines, no increases or decreases in expression relative to the 
negative control were found to be statistically significant (Kruskal-Wallis with Dunn’s).  
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Figure 2.13: Relative abundance of CYP2E1 mRNA transcripts in OKF6 and DOK cells 
exposed to test groups compared to a negative control (RPMI). Values were derived from 
quantification of mean ΔΔCt values calculated using RPL13A (housekeeping gene) as a 
standard. Expressed as quantification relative to control (RQ) with minimum and maximum 
values. 
 
 
2.4 Discussion 
 
This chapter pursued four aims; to demonstrate ethanol-induced genotoxicity in oral 
epithelial cells in response to ACM exposure, to compare the genotoxic potential of ACMs 
with NAMs in-vitro, to investigate the involvement of lipid peroxidation and CYP2E1 
induction in ethanol-induced genotoxicity in cultured oral keratinocytes and to compare the 
magnitude of genotoxicity in normal and dysplasia derived oral epithelial cell lines. These 
aims were pursued concurrently using experiments that contributed data to each aim. The 
results are discussed here after collating the data under the four stated aims. 
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2.4.1 Ethanol within alcohol-containing mouthwashes induces genotoxic changes in oral 
keratinocytes 
 
The single cell gel electrophoresis assay (Comet assay) provided evidence of DNA 
damage in cultured monolayers of normal oral keratinocytes (OKF6) and dysplastic oral 
keratinocytes (DOK) following acute exposure to ACMs or equimolar aqueous solutions of 
ethanol. Acute exposure of cells to ethanol induced DNA strand breaks in a dose-response 
fashion at concentrations that were equimolar with the original formulations of ACMs from 
‘A’ brand (11.5% v/v) and ‘B’ brand (27% v/v). DNA strand breaks were also observed in 
cells following acute exposure to culture media supplemented with ACMs from both ‘A’ and 
‘B’ brands. Removal of ethanol from test groups via centrifugal evaporation and 
reconstitution with water resulted in a reduction in DNA strand breaks when compared to 
the original formulation exposures. Evaporation and reconstitution with ethanol to a final 
ethanol concentration that was equimolar to the original formulation of ACM ‘A’ brand and 
‘B’ brand did not increase DNA strand breaks in ACM solutions when compared to the 
original formulations. Collectively, this data provides strong support of our hypothesis that 
ethanol within alcohol-containing mouthwashes induces genotoxic changes in oral 
keratinocytes and is consistent with previous investigations. Demonstration of DNA strand 
breaks by Comet assay is a recognised in-vitro measure of potential genotoxicity and has 
previously indicated potential genotoxicity of both an ACM with an alcohol content of 27% 
and an equivalent solution of ethanol in cultured oral epithelial cells.142, 169 Using another 
model of genotoxic potential, the Drosophila melanogaster Somatic Mutation and 
Recombination Test, Rodrigues et al. compared the mutation rate among 3 mouthwashes 
and found it to be highest for the product with the highest alcohol content (16.8% v/v), 
whilst eliminating the active ingredient (0.05% cetylpyridinium chloride) as a source of 
genotoxicity.145  
 
2.4.2 Alcohol-containing mouthwashes exhibit greater genotoxic potential than non-
alcoholic mouthwashes 
 
The results of the Comet assay provide evidence that NAMs from both ‘A’ brand and ‘B’ 
brand induced less genotoxic damage to oral keratinocytes than their ACM counterparts. 
Within brands, acute exposure to ACM resulted in significantly higher levels of DNA strand 
breaks than NAM. No significant reduction of DNA strand breaks was observed when 
NAMs were reduced by evaporation and reconstituted with water when compared to the 
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original formulation (as opposed to the ACM groups, which did experience a reduction in 
DNA strand breaks). Interestingly, addition of ethanol to NAM by evaporation and 
reconstitution with an equivalent ethanol solution resulted in increased DNA strand breaks 
in NAM solutions (but not ACM solutions) when compared to the original formulation. 
These results were consistent across both ‘A’ and ‘B’ brands and for both the dysplasia 
derived and normal derived oral epithelial cell lines. These trends indicate that acute 
exposure to NAM induces lesser genotoxic damage in cultured oral keratinocytes than a 
similar exposure to an ACM. The data presented here supports prior published results 
from two studies that used ethanol-negative or reduced ethanol test groups as a 
comparison to the effects of alcohol-containing mouthwash. In both studies, reduced DNA 
damage was observed in samples exposed to test groups with reduced or no ethanol 
when compared to the effects of an ACM.142, 145 In both OKF6 and DOK samples, 
exposure to an NAM did induce greater DNA strand breaks when compared to a negative 
control. This was most likely due to the inclusion of other genotoxic agents within the 
mouthwash formulation, such as the active ingredients of each of the brands. 
 
2.4.3 Insubstantive evidence that neither lipid peroxidation nor CYP2E1 contribute to 
alcohol induced genotoxicity in oral keratinocytes in-vitro 
 
To determine the origin of genotoxicity observed after ethanol exposure, lipid peroxidation 
and CYP2E1 function in oral keratinocytes in response to ACM and NAM exposure was 
investigated. Lipid peroxidation was measured following a 1 hour exposure to solutions of 
‘A’ and ‘B’ brand ACMs and NAMs. In both OKF6 and DOK cells, production of lipid 
peroxides was higher in the NAM groups compared to the ACM groups, which only 
demonstrated a small non-significant increase. Cytochrome P450 2E1 (CYP2E1) activity 
was investigated through measuring both mRNA expression and enzyme function 
following multiple exposures repeated over 1 week. Analysis revealed a lack of both gene 
expression and function in both OKF6 and DOK cell lines following the exposures.  
The lack of association between increased lipid peroxidation or CYP2E1 activity and 
exposure to ethanol appears to indicate that these mechanisms do not contribute 
significantly to ethanol-related genotoxicity in oral keratinocytes in our model. There are a 
number of possibilities for these results. With regards to lipid peroxidation, it is feasible that 
other components present in the mouthwash formulations, as opposed to the presence or 
absence of ethanol, have a greater influence on driving the formation of reactive oxygen 
species and lipid peroxidation in oral keratinocytes. For CYP2E1 functional activity, it was 
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clear that the high performance liquid chromatography method used in the current study 
lacked an adequate level of sensitivity to detect the low level CYP2E1 activity of OKF6 and 
DOK cells. While calibrations found a minimum detection limit for 4-nitrocatechol of 34.44 
ng/mL, this is possibly inadequate. Adoption of more sensitive techniques such as liquid 
chromatography-mass spectrometry was not appropriate since such low levels of enzyme 
activity would not be of physiological relevance. With regards CYP2E1 expression, our in-
vitro model may have been influenced by two factors. First, the cells used in this study 
(OKF6 and DOK) may be constitutive low-expressors of CYP2E1 as has been reported for 
other epithelial lineages. For example, Runge et al. found that the expression of CYP2E1 
in bronchial epithelial cells of 14 separate individuals varied significantly from each other, 
while Farin et al. found that primary oral epithelial cells showed greater mRNA expression 
of CYP2E1 than cultured cell lines leading to the possibility that they lack the differentiation 
to properly express CYP2E1.72, 172 
 
2.4.4 Evidence of elevated genotoxicity in dysplasia derived rather than normal oral 
mucosa derived epithelial cell lines following acute exposure to ACMs and NAMs 
 
The stepwise accumulation of harmful mutations, resulting in a loss of control over cellular 
proliferation, apoptosis and motility, is the process through which oral keratinocytes 
progress towards a malignant phenotype.1 Oral epithelial dysplasia represents a partial 
progression along this pathway, where cellular dysregulation results in both abnormal 
activity and an irregular response to external stimuli (including down-regulation of genes 
related to DNA repair and metabolism of reactive oxygen species).173 At the 
commencement of this study, one of the hypotheses put forth was that dysplastic tissue 
will have an altered susceptibility to the genotoxic effects of ethanol contained within 
ACMs (on account of the previously explained factors). Measurement of DNA strand 
breaks following an acute exposure revealed significantly increased DNA migration in DOK 
cells exposed to a negative control when compared to the corresponding OKF6 group 
(19.23% vs. 8.18%, p < 0.001; Kruskal-Wallis with Dunn’s). In general, greater DNA 
migration was observed in DOK samples than in OKF6. This increase was relatively 
consistent across all mouthwash groups, suggesting that DOK cells produced a greater 
number of DNA strand breaks in response to environmental stress rather than as a result 
of susceptibility to a particular type of mouthwash. A similar pattern of results was 
observed in the measurement of lipid peroxidation following an acute exposure to ACM 
and NAM groups. While the total amount of thiobarbituric acid reactive substances 
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produced in the exposed DOK samples was on average 6-fold that produced in the OKF6 
samples, the increases were consistent and not confined to any particular test group. With 
regards to CYP2E1 expression and function following repeated exposures to ACMs and 
NAMs, no differences were found between the two cell lines. Overall, dysplastic oral 
keratinocytes did demonstrate a different response to mouthwash exposure when 
compared to normal oral keratinocytes, exhibiting higher levels of markers of oxidative 
stress and DNA damage. However, similar increases in the control groups suggest that 
this is a baseline attribute of the DOK cells rather than an effect related to either 
mouthwash or ethanol. Nevertheless, the observation that dysplastic cells have a greater 
susceptibility to genotoxic damage in response to a topical exposure to mouthwash than 
normal cells has significant clinical ramifications. It is difficult to gauge how far along the 
continuum that the DOK cell line used in this study has progressed to malignancy, 
particularly after repeated culture and passage. Inclusion of another reference cell line 
(possibly an OSCC line) in future studies will allow some perspective on this.  
 
2.4.5 Summary of findings 
 
Overall, four main points can be drawn from the results of this study. First, it was found 
that the inclusion of ethanol in mouthwash formulations resulted in genotoxic damage in 
the form of DNA strand breaks in oral keratinocytes following an acute exposure. Second, 
the same exposure with an NAM resulted in significantly less genotoxic damage. Third, no 
significant increase in lipid peroxidation and CYP2E1 induction and function was found to 
have occurred on exposure of oral keratinocytes to ACM exposure. Lastly, dysplastic 
derived cells demonstrated greater amounts of both DNA strand breaks and lipid 
peroxidation (compared to normal derived cells) in response to both ACM and NAM 
exposure, independent of ethanol content. In our proposed model relating to the 
secondary effects of ethanol exposure, the activity of CYP2E1 and the induction of lipid 
peroxidation are both associated with the pathway of oxidative damage. Thus the results 
of this study would appear to indicate that despite evidence of the ethanol content of the 
test groups being related to the induction of DNA strand breaks, oxidative stress induced 
by ethanol exposure does not play a part in this process. 
 
2.4.6 Alternative pathways of ethanol induced genotoxicity  
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It is possible that instead of the primary contribution to DNA damage resulting from the 
generation of reactive oxygen species, other secondary effects are playing a greater role. 
The most likely candidate is acetaldehyde, a byproduct of the metabolic breakdown of 
ethanol, which is recognised as a potent genotoxic agent.17, 66, 67 The enzyme responsible 
for producing acetaldehyde, alcohol dehydrogenase (ADH), has been previously shown to 
be expressed in human oral epithelial cells.43 It is also worth noting that acetaldehyde is 
prominent in past studies investigating the effects of mouthwash in an in-vivo or in-vitro 
setting. As mentioned previously, Rodrigues et al. discovered that ethanol was the ACM 
component that was linked the genotoxicity observed in their study, after which they 
proposed the metabolite acetaldehyde was actually responsible. In human in-vivo studies, 
it has also been observed that one-time use of an ACM resulted in the production of 
acetaldehyde to a point where mutagenicity could theoretically occur.140, 141 The increased 
response of dysplastic cells to external environmental exposures (not just ethanol) is likely 
due to the dysfunction of DNA repair mechanisms and antioxidant mechanisms brought 
about by genomic dysregulation.1  
 
2.4.7 Limitations and future directions 
 
The present investigation applied a series of in-vitro assays to study the effects of ACM 
and NAM on submerged monolayers of oral epithelial cells. For this study cell lines were 
preferable to whole tissue experiment models since the assays required rapid and reliable 
techniques to isolate cells as the first step in lengthy, multistep assay procedures. 
Obviously, the biological relevance of cell monolayer studies can be criticised for; lack of 
an oral environment containing saliva and oral flora, the lack of a stratified epithelium 
containing multiple cell morphologies, the lack of a blood, lymph or immune system, the 
inability to maintain a cultured cell monolayer for a significant period of time and a low 
toxicity threshold. These factors reduce the clinical relevance of the model and also limit 
the durations, repetitions and dosages of the test group exposures that can be conducted. 
A way to compensate for this in future studies would be to investigate using a human oral 
mucosal equivalent (HOME) model.174 The HOME model utilises long-term culture at the 
air-liquid interphase to induce normal patterns of keratinocyte differentiation. This 
approach may have encouraged expression of CYP2E1. Whilst this more realistic three 
dimensional model would allow test group exposures at more realistic dosages and usage 
patterns, it is not readily adaptable to assays that require study of isolated cells since it is 
appreciably more difficult to enzymatically release cells from a dermal substrate than from 
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tissue culture plastic. This approach is most appropriate to IHC based investigations but 
would require comprehensive testing beforehand to determine a viable dose. The hamster 
buccal pouch model would also provide a versatile and relevant model as it allows regular 
topical application of an agent on oral mucosa that histologically resembles human 
tissue.175 However, this approach would require a greater focus on ethics given animal 
involvement. It would have been ideal to investigate the contribution of acetaldehyde to 
any changes as it is one of the main genotoxic byproducts of the breakdown of ethanol, 
however analysis of the generation and effects of acetaldehyde require technical expertise 
and equipment that was not readily available to us in order to conduct headspace gas 
chromatography, and is being pursued by other researchers in this field.41, 59, 140 
Measurement of other points within the ethanol-related genotoxic process will allow a more 
complete picture of the effects of ethanol within the oral cavity to be formulated. In order to 
reconcile the seemingly conflicting results of this study, further investigation is required. 
Ideally this will focus on other pathways leading from exposure to ethanol, particularly 
relating to the generation of acetaldehyde. It is also advisable to consider using an 
alternative model (for the reasons discussed above) and to rework the test group exposure 
protocol to reflect a more realistic pattern of mouthwash usage if this is the case. 
 
2.5 Conclusion 
 
Overall, the results from this study suggest that the presence of ethanol as a component of 
mouthwash formulations contributes to the induction of DNA damage in cultured human 
oral keratinocytes following an acute exposure. Further investigations reveal that both 
CYP2E1 enzyme activity and lipid peroxidation were not increased by alcohol-containing 
mouthwash exposure (compared to a non-alcoholic mouthwash), suggesting against the 
involvement of an oxidative damage pathway (as previously hypothesised). Further 
investigation is required into other possible pathways and with biological models better 
suited for investigating the effects of long-term, repeated exposure to mouthwashes. 
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3.1 Introduction 
 
Oral squamous cell carcinoma (OSCC) is a neoplastic condition that is characterised by 
the malignant transformation of oral keratinocytes. It is a significant medical issue, being 
the 8th most common malignancy in men and the 13th most common malignancy in women 
on a worldwide basis.3 It has been theorised that malignant change is brought about by 
genetic injury to the cells of the oral mucosa, leading to the development of a potentially 
malignant phenotype. Clonal expansion and growth increases the number of these 
susceptible cells, which may acquire additional genetic changes that increase their 
malignant potential. Thus progression occurs from normal cells to hyperplasia to varying 
grades of dysplasia and finally an invasive carcinoma that is able to proliferate in the 
absence of stimulation and ignore pro-apoptotic signals.96 OSCC does not develop as a 
result of a mutation in a single crucial gene, but multiple mutations affecting genes whose 
products regulate the cell cycle, growth, motility, angiogenesis and apoptosis.176 Some 
examples of mutations commonly seen in OSCC tumours include those in the genes 
controlling the expression of EGFR (a growth factor receptor), H-RAS (a mitogenic 
protein), Cyclin D1 (a cell cycle regulator) and p53 (a cell cycle regulator that can induce 
apoptosis).177-180 
 
There are several major established risk factors that have been linked to the development 
of OSCC due to their ability to induce genetic injury. These include the consumption of 
alcoholic beverages, tobacco products and betel quid.2 As use of betel quid is primarily 
confined to India, South-East Asia and the Pacific Islands, in Western societies an 
estimated 80% of population attributable risk for OSCC is due to consumption of alcohol 
and tobacco.2, 5, 8-11 Even independent of other factors, alcohol has been shown to have a 
significant impact on risk, with a large meta-analysis showing heavy drinking (≥4 
drinks/day) produces a relative risk of 5.24 (95% CI, 4.36-6.30) compared to a non-
drinker.32 While ethanol itself is not a direct carcinogen, it produces a cascade of 
damaging secondary effects that cause genetic damage.15 Mechanisms through which 
ethanol is theorised to cause genetic damage in oral keratinocytes include the production 
of the carcinogenic metabolite acetaldehyde by metabolic enzymes, up-regulation of 
cytochrome P450 2E1 (which induces oxidative stress and activates procarcinogens) and 
the production of mutagenic reactive oxygen species and lipid peroxidation products.41-43, 
68-70, 82, 83, 89-91, 97, 99 The sum of these effects is a sustained insult on the integrity of the 
genome. 
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One factor that has come under scrutiny in the past in relation to OSCC risk is the chronic 
use of high alcohol-containing mouthwashes (ACMs). Ethanol is a key ingredient in the 
majority of commercially available mouthwashes, acting as a solvent, preservative, 
antiseptic and caustic agent. The concentration of ethanol varies between products, but 
can be as high as 26% v/v (higher than some alcoholic beverages).92 While 
epidemiological studies and reviews have investigated the relationship, they have 
produced largely divided findings.6, 108, 111-116, 119, 120, 122-124, 129-135 A number of in-vitro and 
in-vivo studies have also investigated the effects of ACMs. Lachenmeier et al. showed that 
a 30 second exposure to an ACM can generate theoretically mutagenic levels of 
acetaldehyde in the saliva while another study found a significantly increased number of 
nuclear abnormalities in exfoliated buccal cells of volunteers who used ACMs twice-daily 
for a month (when compared to controls and a group using non-alcoholic mouthwash).140, 
141, 144  Rodrigues et al. investigated ACM-induced mutagenicity using a Drosophila 
melanogaster Somatic Mutation and Recombination Test and found that as the alcohol 
content of the mouthwash increased, so did the incidence of mutation events.145 Another 
study has also shown that greater numbers of DNA strand breaks were observed in oral 
keratinocytes exposed to a solution of an ACM in an in-vitro environment when compared 
to an ethanol free group.142 Overall, there is a lack of literature relating to the cellular and 
molecular effects of repeated exposure to ACMs.  
 
The term ‘next-generation sequencing’ (NGS) refers to a group of technologies that are 
seen as successors to the traditional method of Sanger DNA sequencing. Their 
development has made it possible to generate large volumes of genomic data (over a 
billion reads) relatively cheaply. This allows a myriad of applications including whole 
genome sequencing, whole exome sequencing and targeted gene sequencing.181 
Sequencing of the exome (the segments of DNA that encode proteins) is particularly 
valuable from a clinical perspective as it is estimated that changes to these regions 
constitute approximately 85% of disease causing mutations.182 NGS has been utilised in 
several studies to sequence the tumour exomes of samples from head and neck SCC 
(HNSCC) patients. Stransky et al. found an average of 130 coding mutations per tumour 
and identified mutations in 39 known genes over the population tested, while Agrawal et al. 
observed somatic mutations in genes already associated with the development of OSCC. 
Both studies also independently identified significant mutations in the signalling gene 
NOTCH1, which had not been previously associated with HNSCC.183, 184  
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In addition to DNA sequencing, NGS can also be utilised to sequence the RNA transcriptome 
(RNA-Seq). The transcriptome represents the entirety of a sample’s transcribed RNA and 
sequencing allows both quantification of relative gene expression and identification of 
nucleotide polymorphisms. Until now, investigation of RNA expression has utilised gene 
expression microarrays, which rely on the hybridisation and fluorescence of pre-crafted 
probes. While gene expression microarrays are a well-established molecular technique with 
a strong body of literature, RNA-Seq has several advantages.185 Firstly, RNA-Seq does not 
require prior knowledge of the structure of the genes being investigated, thus eliminating the 
need for crafted probes.186 Unlike gene expression microarray, there is also no limit on the 
number of genes that can be simultaneously investigated.  RNA-Seq also allows the 
identification of other transcriptomic changes, such as single nucleotide polymorphisms, 
differential splice variants, chromosomal translocations, fusion genes and viral transcripts.187-
192 In their study, Tuch et al. found and confirmed with real-time quantitative reverse 
transcriptase polymerase chain reaction (RT-qPCR) that RNA-Seq was better than gene 
expression microarray at identifying differential expression in transcripts with low expression 
levels.190 RNA-Seq has been utilised in several studies examining gene expression and 
transcriptome variation in several types of HNSCC, including oral, esophageal and 
oropharyngeal.  Demonstrated applications of RNA-Seq in these studies include 
quantification of differential gene expression, gene ontology analysis to identify over-
represented, under-represented and dysregulated biological processes, identification of 
chromosomal translocations and subsequent fusion genes, identification of differentially 
expressed novel mRNA splice variants and investigation for HPV and other viral mRNA 
transcripts.188, 190-195 
 
The Ion Proton™ / Ion Personal Genome Machine™ (PGM) system from Life 
Technologies™ (Carlsbad, USA) is an NGS platform that utilises proton release 
associated with DNA polymerisation to determine nucleotide sequence (ion semiconductor 
sequencing). Clonally amplified DNA fragments are placed within micro-machined wells 
fitted with pH sensors and challenged with free nucleotides. Incorporation of nucleotides 
releases a proton, generating measurable pH change. This process is repeated with a 
cycle of nucleotides, thus developing a DNA sequence.196 Compared to other NGS 
technologies, ion semiconductor sequencing is faster and cheaper but suffers from a 
shorter read length and higher error rate. However, it has been shown to be accurate in 
identifying nucleotide polymorphisms.197, 198  
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As mentioned previously, there is limited literature regarding the effects of alcohol-
containing mouthwash exposure on oral keratinocytes, especially in relation to the 
changes that occur over time in response to repeated exposures. Based on the available 
literature relating to ethanol-associated genotoxicity and the effects of alcohol containing 
mouthwash exposure, a tripartite hypothesis was formulated. First, that repeated exposure 
to ACMs and non-alcoholic mouthwashes (NAMs) will induce transcriptomic changes in 
oral keratinocytes in comparison to a negative control exposure. Second, that the 
expression changes in genes associated with ethanol-related genotoxicity will be greater in 
the samples exposed to ACMs compared to the NAMs. Third, that dysplastic tissue as 
opposed to normal tissue will exhibit greater transcriptomic changes in response to 
repeated ACM exposure. Therefore, the aim of this chapter was to use RNA-Seq data to 
investigate transcriptomic changes brought about in oral keratinocytes by repeated ACM 
and NAM exposure, particularly in gene pathways associated with ethanol-related 
genotoxicity. The secondary aim was to investigate whether these transcriptomic changes 
differed between normal and dysplastic tissues.  
 
The aims of this study were investigated in an in-vitro environment using 2 cultured cell 
lines derived from normal and dysplastic oral mucosa. Repeated exposures to solutions of 
ACMs and NAMs occurred in controlled culture conditions according to the chronic 
exposure protocol developed in Chapter 2. In order to test the postulated hypotheses, 
sequencing of the RNA transcriptome following completion of the exposures was utilised 
as it provides a comprehensive profile of gene expression along with the potential for other 
investigations such as gene ontology. Lastly, data from an initial pilot run was used to 
redesign the methodology of the primary experiment to maximise fulfilment of the aims of 
the chapter.  
 
3.2 Materials and Methods 
 
Cell Culture 
hTERT transfection immortalised normal human oral keratinocytes (OKF6) at passage 22 
and dysplastic human oral keratinocytes (DOK) at passage 21 were seeded in 75 cm2 
flasks at a density of 2x106 cells/flask and cultured in Dulbecco’s Modified Eagle 
Medium/Nutrient Mixture F-12 (DMEM/F-12) containing 10% fetal bovine serum (FBS) and 
1% antibiotic-antimycotic (ABAM) to 100% confluence. All tissue culture media and 
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reagents were purchased from Invitrogen (Carlsbad, USA) and Sigma-Aldrich (St Louis, 
USA).  
 
Cell Treatment 
Sample groups consisted of four commercially available mouthwashes, two alcohol-
containing mouthwashes (ACMs) and two non-alcoholic mouthwashes (NAMs), 1 each 
from two parent brands (‘A’ and ‘B’); A-ACM (Chlorhexidine Gluconate 1.28 mg/mL + 
Ethanol 96 mg/mL), A-NAM (Chlorhexidine Gluconate 2 mg/mL), B-ACM (Ethanol 213.03 
mg/mL +  Methyl Salicylate 0.6 mg/mL + Thymol 0.64 mg/mL + Eucalyptol 0.92 mg/mL) 
and B-NAM (Sodium Fluoride 0.22 mg/mL + Methyl Salicylate + Thymol + Eucalyptol). 
DMEM/F-12 media + 10% FBS + 1% ABAM was included as a negative control. An ideal 
test exposure of 0.5% concentration for 10 min was determined by performing toxicity 
assays utilising an Incucyte™ kinetic imager (Essen BioScience, Ann Arbor, USA). 
Sample groups were diluted to their test concentration in DMEM/F-12 containing 10% FBS 
and 1% ABAM. Cells were exposed to test groups for 10 mins, twice daily for 7 days. Two 
complete runs of the experiment were performed; a pilot study to determine the viability of 
the technique followed by a main study. The exposure groups utilised in each iteration of 
the experiment are summarised in Table 3.1. Following the final exposure, cells were 
allowed to recover for 2 hr before harvesting. All groups were photographed on an 
Incucyte™ kinetic imager both at Day 0 and after the final exposure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
69 
 
Table 3.1: Summary of cell lines and exposure groups utilised in both the pilot study and 
the main study. 
PILOT STUDY 
Cell Line Exposure Harvested Biological Replicates 
OKF6 
Negative Control Day 0 1 
Negative Control Day 7 1 
A-ACM Day 7 1 
A-NAM Day 7 1 
B-ACM Day 7 1 
B-NAM Day 7 1 
DOK 
Negative Control Day 0 1 
Negative Control Day 7 1 
A-ACM Day 7 1 
A-NAM Day 7 1 
B-ACM Day 7 1 
B-NAM Day 7 1 
MAIN STUDY 
Cell Line Exposure Harvested Biological Replicates 
OKF6 
Negative Control Day 7 3 
A-ACM Day 7 3 
A-NAM Day 7 3 
B-ACM Day 7 3 
B-NAM Day 7 3 
DOK 
Negative Control Day 7 3 
A-ACM Day 7 3 
A-NAM Day 7 3 
B-ACM Day 7 3 
B-NAM Day 7 3 
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RNA and DNA Isolation 
Cells were washed 2 times with PBS before trypsinisation at 37°C with TrypLE Express 
and collection in 10 mL of DMEM/F-12 containing 10% FBS and 1% ABAM. This was 
followed by centrifugation at 900 rpm for 5 min and discarding of the supernatant. Cells 
were resuspended in 1 mL of PBS and centrifuged at 900 rpm for 5 min, followed by 
discarding of the supernatant. RNA and DNA were extracted using AllPrep 
DNA/RNA/miRNA Universal Kit (Qiagen, Venlo, Netherlands) according to the 
manufacturer’s instructions. For each sample, the cell pellet was homogenised in the 
provided buffer (containing β-mercaptoethanol), transferred to a DNA spin column and 
centrifuged at 18000 g for 30 sec. While the DNA-containing spin column was stored at 
4°C, Proteinase K and absolute ethanol was incubated at room temperature for 10 min 
and followed by the addition of additional absolute ethanol. The sample was transferred to 
a RNA spin column and centrifuged at 18000 g for 15 sec. This was followed by the 
addition of buffer, centrifugation at 18000 g and discarding of flow-through. The column 
was then incubated with DNAse I at room temperature for 15 min. This was followed by 
the addition of buffer, centrifugation at 18000 g and the recentrifugation of the flow-
through. The washing step was repeated with buffer followed by ethanol. After drying of 
the spin column membrane, RNA (including miRNA) was eluted in 80 µL RNAse-free 
water by centrifugation at 8000 g for 1 min and stored at -80°C. Buffer was added to the 
stored DNA spin column, centrifuged at 8000 g for 15 sec and the flow-through was 
discarded. Following 5 min incubation with Proteinase K, the column was washed twice 
with buffer. The DNA was then eluted into 150 µL buffer through addition, incubation for 1 
min at room temperature and centrifugation at 8000 g for 1 min. This was then stored at -
80°C. The quality and quantity of DNA and RNA was assayed utilising a Nanodrop 1000 
spectrophotometer (Thermo Scientific, Waltham, USA) and RNA was analysed on a RNA 
6000 Nano chip in a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, USA).  
 
RNA Transcriptome Library Preparation 
RNA whole transcriptome libraries were constructed for sequencing on the Ion Proton™ 
system (Life Technologies, Carlsbad, USA). 1 µg of total RNA was depleted of rRNA using 
a RiboMinus™ Eukaryote System v2 (Life Technologies) according to the manufacturer’s 
instructions. Total RNA was incubated with hybridisation buffer and probe mix for 10 min at 
70°C followed by cooling to 37°C over 20 min. Magnetic beads were isolated, washed and 
suspended in 200 µL of hybridisation buffer. The RNA/probe mix was added to the 
prepared beads and incubated at 37°C for 5 min. The beads were then collected using a 
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magnetic stand and the supernatant collected. This was then incubated with nucleic acid 
binding beads, binding solution and absolute ethanol and incubated for 5 min at room 
temperature. A magnetic stand was used to collect the beads before discarding the 
supernatant. After washing and air drying the beads, the rRNA-depleted RNA was eluted 
in 12 µL nuclease-free water by incubation for 1 min at room temperature. The rRNA-
depleted samples were quantified using a Qubit® RNA Assay Kit on a Qubit® 2.0 
Fluorometer (Life Technologies) before analysis on a RNA 6000 Pico chip in a 2100 
Bioanalyzer (Agilent Technologies). 50 ng of rRNA-depleted sample was fragmented by 
incubation with 1 unit each of RNAse III and reaction buffer for 3 min at 37°C followed by 
addition of nuclease-free water and storage on ice. 30 µL of fragmented RNA was added 
to a mixture of nucleic acid binding beads and binding solution followed by the addition of 
150 µL absolute ethanol. Following incubation for 5 min at room temperature, the beads 
were magnetically separated from the solution and the supernatant discarded. Beads were 
then briefly washed and air dried. To elute the RNA, the beads were incubated in pre-
warmed nuclease-free water for 1 min. Following this, the RNA was analysed for yield and 
size distribution using a Qubit® RNA Assay Kit on a Qubit® 2.0 Fluorometer and a RNA 
6000 Pico chip in a 2100 Bioanalyzer. To perform hybridisation and ligation, 100 ng of 
fragmented and purified RNA was incubated in hybridisation buffer for 10 min at 65°C 
followed by 5 min at 30°C, followed by the addition of ligation enzyme mix and incubation 
for 1 hr at 30°C. To perform reverse transcription (RT), a master mix was formulated 
containing nuclease-free water, RT buffer, 2.5 mM dNTP mix and Ion RT primer v2 and 16 
µL was added to the hybridisation/ligation reaction and incubated for 10 min at 70°C. This 
was followed by addition of 4 µL of 10X SuperScript® III enzyme mix and incubation for 30 
min at 42°C to produce cDNA. In order to purify the cDNA, a mixture of nucleic acid 
binding beads in binding solution was prepared and the contents of the RT reaction added 
along with 125 µL absolute ethanol. Following 5 min of incubation at room temperature, 
the beads were separated from the mixture and the supernatant discarded. After brief 
washing and air drying, purified cDNA was eluted in 12 µL of pre-warmed nuclease-free 
water. To amplify the cDNA, 6 µL of sample was added to 47 µL of master mix containing 
Platinum® PCR SuperMix High Fidelity, Ion 5’ PCR Primer v2 and Ion 3’ PCR Primer v2. 
The mixture was then processed in thermal cycler for 2 min at 94°C, 2 cycles of 94°C, 
50°C and 68°C for 30 sec each, 16 cycles of 94°C, 62°C and 68°C for 30 sec each and 
finally 5 min at 68°C. This was followed by a repeat of the bead based purification and 
elution of the cDNA in 15 µL of pre-warmed nuclease-free water. cDNA was then analysed 
for concentration and size distribution using a Qubit® dsDNA HS Assay Kit on a Qubit® 
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2.0 Fluorometer and a DNA 1000 chip in a 2100 Bioanalyzer. After confirmation that >50% 
of the cDNA lay within the 50-160 bp range, samples were diluted in low TE to a final 
library concentration of 14 pM.  
 
Template Preparation 
Templates for sequencing were produced using the Ion PI™ Template OT2 200 Kit v3 for 
the Ion OneTouch™ 2 System (Life Technologies). Firstly, an amplification solution was 
formulated containing Ion PI Reagent TL, Ion PI PCR Reagent B, Ion PI Enzyme Mix TL, , 
Ion PI Ion Sphere™ Particles and diluted cDNA library to a volume of 1500 µL. This 
solution was immediately transferred to an Ion PI Plus Reaction Filter followed by addition 
of 950 µL of Ion Proton OT2 Reaction Oil. The reaction filter was inserted into the 
OneTouch 2 System and the Ion Sphere particle enrichment program initiated. Following 
completion of the program, the template-positive Ion Sphere particles were resuspended in 
100 µL of recovery solution, followed by a rinse with 100 µL of nuclease-free water to 
recover excess particles. This suspension was brought up to 1 mL with nuclease-free 
water and centrifuged for 8 min at 15,500 g. After removing 900 µL of supernatant, the 
suspension was once again brought up to 1 mL with nuclease-free water and centrifuged 
for 8 min at 15,500 g. After removing 980 µL of supernatant, the particles were 
resuspended in 80 µL of Ion PI ISP Resuspension Solution. Before proceeding to 
enrichment, the quality of the template-positive IonS phere particles was assessed utilising 
a Qubit® 2.0 Fluorometer. Enrichment of the Ion Sphere particles was performed using the 
Ion OneTouch ES. An 8-well strip was set up with Ion Sphere particle solution, 
Dynabeads® MyOne™ Streptavidin C1 Beads suspended in Ion PI MyOne Beads Capture 
Solution, OneTouch Wash Solution and Melt-Off Solution (NaOH, 10% Tween 20 and 
nuclease-free water) in their assigned wells and the enrichment program was initiated. 
Following completion of the program, the Ion Sphere particles were centrifuged for 5 min 
at 15,500 g, the supernatant discarded and the pellet resuspended in 200 µL nuclease-
free water.  
 
RNA Transcriptome Sequencing 
Preparation for sequencing was carried out using an Ion PI Sequencing 200 Kit v3 (Life 
Technologies). 5µL of Ion PI Control Ion Sphere particles were added to the previously 
prepared template-positive Ion Sphere particles and centrifuged for 5 min at 15,500 g. All 
bar 10 µL of supernatant was removed and discarded, followed by the addition of 15 µL of 
Ion PI Annealing Buffer and 20 µL of Ion PI Sequencing Primer. The mixture was then 
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incubated for 2 min at 95°C and 2 min at 37°C, followed by the addition of 10 µL of Ion PI 
Loading Buffer. The entire prepared sample was loaded onto a prepared and calibrated 
Ion PI Chip v2 and centrifuged for 10 min in the Ion Chip™ Minifuge. 100 µL of a foamed 
mixture of 50% Annealing Buffer and 2% Triton X-100 was injected into the chip, followed 
by 55 µL of 50% Annealing Buffer and 30 sec of centrifugation. This process was repeated 
once before two washes with 100 µL of Flushing solution. 100 µL of 50% Annealing Buffer 
was injected into the chip 3 times, followed by 65 µL of a solution of 6 µL Ion PI 
Sequencing Polymerase in 50% Annealing Buffer. Following 5 min of incubation at room 
temperature, the chip was loaded onto the Ion Proton system and sequenced for 500 
flows, resulting in 70,000.000 to 90,000,000 reads per chip (after quality filtering to remove 
low quality bases from 3’ end). The reads were split according to barcodes using the 
program Torrent Suite 4.2 (Life Technologies). 
 
RNA-Seq Bioinformatics – Pilot Study 
Raw reads were quality checked with fastQC (The Babraham Institute, Cambridge, UK) for 
sequence quality, GC Content, sequence duplication level etc. Reads were then trimmed 
using the Trimmomatic tool prior to mapping.199 Remaining reads were then mapped to the 
human reference genome hg19 using the R package Rsubread.200 QC figures of the 
mapped raw read counts were plotted and investigated for potential outliers. Hierarchical 
clustering was performed using the Euclidean distances matrix calculated from the 
mapped read counts for the 30 most highly expressed genes after normalisation. A 
Principal Component Analysis was performed using the mixOmics package.201 Differential 
gene expression was calculated using the R package Limma, which applies a linear model 
to read counts before computing t-tests and adjusting for multiple testing using the 
Benjamini and Hochberg method.202 
 
RNA-Seq Bioinformatics – Main Study 
Raw reads were quality checked with fastQC (The Babraham Institute) for sequence 
quality, GC Content, sequence duplication level etc. Sequences were mapped to the 
human reference genome hg19 using the Burrows-Wheeler Aligner.203 Following mapping, 
the application RNAseQC was used to generate descriptive QC of the mapped reads 
(proportions of reads mapped to exonic, intronic and intergenic sequences).204 The R 
package Rsubread was then used to extract the number of reads mapped to each gene, 
which were plotted and investigated for potential outlier libraries.200 Hierarchical clustering 
was performed using the Euclidean distances matrix calculated from the mapped read 
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counts for the 30 most highly expressed genes after the Variance Stabilizing 
Transformation. A Principal Component Analysis was performed using the mixOmics 
package with the VSD transformed data.201 Differential gene expression was calculated 
using the R package Limma, which applies a linear model to read counts before computing 
t-tests and adjusting for multiple testing using the Benjamini and Hochberg method.202 The 
R package Vennerable was used to plot Venn diagrams of the intersection between lists of 
differentially expressed genes. Pathway enrichment analysis of the significantly 
differentially expressed genes for each comparison was done using the MetaCore pathway 
analysis tool for GeneGO (Thomson Reuters, New York City, USA). P-values were 
calculated using the hypergeometric test and adjusted for multiple testing using the ‘false 
discovery rate’ method. 
 
3.3 Results 
 
 
Oral Keratinocyte Transcriptome Changes Following Mouthwash Exposure – Pilot Data 
A preliminary study was designed and performed to confirm the viability of both the 
exposure protocols and the transcriptome sequencing process. A single biological 
replicate of both normal oral keratinocytes (OKF6) and dysplastic oral keratinocytes (DOK) 
were exposed to the negative control group and the four mouthwash test groups according 
to the 7 day repeated exposure protocol described previously. Following completion of the 
protocol, RNA was extracted and the transcriptome sequenced. Before the exposures 
commenced a Day 0 control was also extracted, stored and sequenced along with the 
other groups.  
 
fastQC analysis prior to trimming revealed an average quality score per read of 
approximately 24 (Phred score). Individual reads varied in length up to 366 bases, with an 
average of 80 bases per read. Trimming was performed to improve the quality of the base 
reads, particularly at the tail end of the longer reads. The improvement in base quality is 
seen in the plots below showing the OKF6 Day 7 Negative Control library before (Figure 
3.1) and after (Figure 3.2) trimming with the Trimmomatic tool.  
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Figure 3.1: OKF6 Day 7 Negative Control transcriptome library per base quality score 
histogram prior to trimming. 
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Figure 3.2: OKF6 Day 7 Negative Control transcriptome library per base quality score 
histogram following trimming. 
 
 
Following trimming, reads were mapped to the human reference genome, demonstrating 
an average match rate of 93.03%. Details of this process are shown in Table 3.2. 
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Table 3.2: Statistics of mapping to human reference genome hg19 for all sample libraries. 
Sample Input Reads Mapped Reads 
OKF6 Day 0 Negative Control 27,753,572 91.26% 
OKF6 Day 7 Negative Control 18,698,188 93.75% 
OKF6 A-ACM 16,264,375 93.98% 
OKF6 A-NAM 11,124,209 89.51% 
OKF6 B-ACM 18,557,030 92.07% 
OKF6 B-NAM 22,154,235 93.16% 
DOK Day 0 Negative Control 22,320,932 94.07% 
DOK Day 7 Negative Control 20,643,944 93.57% 
DOK A-ACM 16,629,109 93.37% 
DOK A-NAM 14,774,341 93.20% 
DOK B-ACM 21,097,258 95.28% 
DOK B-NAM 22,559,738 93.10% 
Average 19,381,411 93.03% 
 
Hierarchical clustering of all samples for the 30 most highly expressed genes was 
performed. Samples were found to cluster primarily to the cell line from which they 
originated (OKF6 and DOK). Within these clusters, samples further clustered according to 
the exposure they received, particularly by brand (i.e. A-ACM and A-NAM vs. B-ACM and 
B-NAM). It was also observed that the Day 7 Negative Control group tended to cluster 
closer to the other repeated exposure groups as opposed to the Day 0 Negative Control, 
suggesting a significant influence of culture time upon the transcriptome. 
 
Principal Component Analysis (PCA) was also performed for the sequenced samples. The 
relevant plots are shown below, stratified according to culture time (Figure 3.3) and the 
test groups (Figure 3.4). Similarly to the hierarchical clustering, primary grouping is 
observed according to cell line and secondary grouping occurring on the basis of culture 
time. Otherwise, samples tend to group closely together within their individual cell lines. 
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Figure 3.3: Principal Component Analysis of sequenced samples, stratified on the basis of 
culture time. Samples from OKF6 and DOK cell lines are labelled. 
 
 
 
 
 
 
 
 
 
Day 0  Day 7  
 
DOK OKF6 
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Figure 3.4: Principal Component Analysis of sequenced samples, stratified according to 
treatment. Samples from OKF6 and DOK cell lines are labelled. 
 
Differential gene expression between control and test groups for both OKF6 and DOK cell 
lines was also investigated. Expression between groups was compared on the basis of 
mouthwash brand (control vs. ‘A’ brand vs. ‘B’ brand) and mouthwash ethanol content 
(control vs. ACM vs. NAM). In OKF6 cells, significant differential gene expression (p < 
0.01; Student’s t-test) was noted in the comparison of the negative control and ‘B’ brand 
mouthwashes (7 genes) and the two separate brands (11 genes), but not in the 
comparison of the negative control and the ‘A’ brand mouthwashes. A greater number of 
significantly differentially expressed genes were observed in the DOK cells, with the 
Day 0 Control 
Day 7 Control 
A-ACM 
  A-NAM 
B-ACM 
    B-NAM 
DOK OKF6 
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negative control and ‘A’ brand mouthwashes (64 genes), negative control and ‘B’ brand 
mouthwashes (8 genes) and the two separate brands (219 genes) being compared (Table 
3.3). No significantly differentially expressed genes were observed when comparing 
negative control, ACMs and NAMs (Table 3.4).  
 
Table 3.3: Number of significantly differentially expressed genes (p < 0.01; Student’s t-
test) between control (Day 7), ‘A’ brand and ‘B’ brand groups in OKF6 and DOK cells. 
 OKF6 DOK 
A-Brand B-Brand A-Brand B-Brand 
Control 0 7 64 8 
A-Brand  11  219 
 
Table 3.4: Number of significantly differentially expressed genes (p < 0.01; Student’s t-
test) between control (Day 7), ACM and NAM groups in OKF6 and DOK cells. 
 OKF6 DOK 
ACM NAM ACM NAM 
Control 0 0 0 0 
ACM  0  0 
 
Oral Keratinocyte Transcriptome Changes Following Mouthwash Exposure – Main Data 
Following validation of the quality of the sequencing data produced in the pilot study, the 
exposure protocol was repeated with the same test groups. Three biological replicates 
each of both normal oral keratinocytes (OKF6) and dysplastic oral keratinocytes (DOK) 
were exposed to the five groups (one control group, four test groups) according to the 7 
day repeated exposure protocol. In this iteration a Day 0 control was not included. 
Following completion of the protocol, RNA was extracted and the transcriptome 
sequenced. 
 
QC analysis revealed an average quality score per read of approximately 24 (Phred 
score). Read length varied from around 10 bases up to 370 bases, with most reads around 
130 bases long. A sequence duplication level of approximately 70% was observed, which 
is considered above average. Following QC analysis, reads were mapped to the human 
reference genome hg19. The relevant mapping statistics are displayed in Table 3.5 and 
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Table 3.6. Descriptive statistics regarding percentage of reads mapped to exonic, intronic 
and intergenic regions are displayed in Table 3.7 and 3.8. 
 
Table 3.5: Statistics of mapping to human reference genome hg19 for OKF6 sample 
libraries. 
Sample Replicate Input Reads Mapped Reads 
OKF6 – Neg Control 
1 
27,345,893 93.44% 
2 
28,921,638 92.62% 
3 
35,262,086 93.84% 
OKF6 – A-ACM  
1 
28,267,364 93.09% 
2 
26,801,150 92.35% 
3 
25,434,366 90.22% 
OKF6 – A-NAM  
1 
24,909,650 93.18% 
2 
26,740,222 88.15% 
3 
21,903,563 92.01% 
OKF6 – B-ACM  
1 
25,215,951 94.37% 
2 
25,552,298 90.36% 
3 
20,444,960 92.03% 
OKF6 – B-NAM  
1 
28,936,679 92.24% 
2 
29,733,028 92.27% 
3 
23,753,785 90.48% 
Average  
26,614,842 92.04% 
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Table 3.6: Statistics of mapping to human reference genome hg19 for DOK sample 
libraries. 
Sample Replicate Input Reads Mapped Reads 
DOK – Neg Control 
1 
22,838,789 92.05% 
2 
17,457,756 87.83% 
3 
17,627,946 85.54% 
DOK – A-ACM  
1 
20,218,578 88.80% 
2 
18,567,024 88.10% 
3 
19,079,308 90.13% 
DOK – A-NAM  
1 
20,971,639 90.64% 
2 
22,199,918 88.57% 
3 
20,948,852 94.20% 
DOK – B-ACM  
1 
29,447,229 94.81% 
2 
23,241,039 95.45% 
3 
32,586,366 95.61% 
DOK – B-NAM  
1 
27,057,461 95.05% 
2 
58,128,253 94.34% 
3 
44,174,110 94.36% 
Average  
26,302,951 91.70% 
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Table 3.7: Descriptive statistics of mapped reads for OKF6 sample libraries regarding 
mapping location. 
Sample Replicate Exonic 
Rate 
Intronic 
Rate 
Intergenic 
Rate 
OKF6 – Neg Control 
1 50.10% 28.90% 21.10% 
2 49.70% 28.10% 22.20% 
3 49.70% 30.10% 20.20% 
OKF6 – A-ACM  
1 49.70% 28.60% 21.70% 
2 49.00% 30.20% 20.70% 
3 50.30% 27.40% 22.30% 
OKF6 – A-NAM  
1 42.90% 30.40% 26.70% 
2 43.40% 29.60% 27.00% 
3 45.80% 30.10% 24.10% 
OKF6 – B-ACM  
1 46.70% 31.30% 22.00% 
2 45.50% 28.40% 26.00% 
3 44.70% 32.60% 22.70% 
OKF6 – B-NAM  
1 45.10% 31.80% 23.10% 
2 45.00% 35.20% 19.80% 
3 44.60% 32.40% 23.10% 
Average  46.81% 30.34% 22.85% 
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Table 3.8: Descriptive statistics of mapped reads for DOK sample libraries regarding 
mapping location. 
Sample Replicate Exonic 
Rate 
Intronic 
Rate 
Intergenic 
Rate 
DOK – Neg Control 
1 50.50% 26.20% 23.30% 
2 48.50% 26.40% 25.10% 
3 48.90% 26.70% 24.30% 
DOK – A-ACM  
1 48.80% 26.50% 24.70% 
2 50.90% 26.80% 22.30% 
3 48.10% 27.60% 24.30% 
DOK – A-NAM  
1 49.50% 27.90% 22.60% 
2 49.30% 27.20% 23.50% 
3 50.30% 27.60% 22.10% 
DOK – B-ACM  
1 50.40% 26.40% 23.20% 
2 51.40% 26.80% 21.80% 
3 49.90% 27.70% 22.30% 
DOK – B-NAM  
1 50.40% 26.20% 23.40% 
2 50.70% 25.00% 24.30% 
3 46.40% 32.30% 21.30% 
Average  49.60% 27.15% 23.23% 
 
Once again, hierarchical clustering of all samples for the 30 most highly expressed genes 
was performed (Figure 3.4). Similar to the pilot study results, samples were found to 
primarily cluster to their cell line of origin. Within the DOK cluster, samples further 
clustered according to the absence or presence of alcohol in the test group (negative 
controls clustered independently). On the other hand, clustering observed within the OKF6 
group was not as defined. 
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Figure 3.5: Hierarchical clustering of all samples using the 30 most highly expressed 
genes.  
 
Principal Component Analysis (PCA) was performed for the sequenced samples as per 
previously (Figure 3.5). Plotting of the proportion of variance revealed that the 1st 
dimension of separation explains approximately 40% of the variability of the data. Analysis 
shows that this discrete grouping occurs on the basis of cell line (OKF6 and DOK). The 2nd 
dimension of the analysis reveals two outliers that vary significantly from their respective 
cell lines, one from the OKF6 cell line (A-NAM replicate 1) and one from the DOK cell line 
(B-NAM replicate 3). These outliers are also visible in the results of the hierarchical 
clustering (see Figure 3.4). Together, the combined influence of the cell lines and the 
outliers explained approximately 50% of the variability in the dataset (Figure 3.6). In order 
to evaluate differences in expression between samples originating from the same cell line, 
3691 
1308 
3914 
79026 
3852 
3918 
60 
6085 
26851 
4550 
4549 
2316 
4627 
3853 
26768 
7057 
7045 
7094 
1956 
718 
780851 
6023 
2355 
378706 
125050 
26855 
3872 
85495 
6060 
6029 D
O
K
 B
-N
A
M
 3
 
D
O
K
 A
-N
A
M
 3
 
D
O
K
 A
-N
A
M
 1
 
D
O
K
 A
-N
A
M
 2
 
D
O
K
 B
-N
A
M
 2
 
D
O
K
 B
-N
A
M
 1
 
D
O
K
 B
-A
C
M
 1
 
D
O
K
 B
-A
C
M
 3
 
D
O
K
 B
-A
C
M
 2
 
D
O
K
 A
-A
C
M
 3
 
D
O
K
 A
-A
C
M
 2
 
D
O
K
 A
-A
C
M
 1
 
D
O
K
 C
o
n
tro
l 1
 
D
O
K
 C
o
n
tro
l 2
 
D
O
K
 C
o
n
tro
l 3
 
O
K
F
6
 A
-N
A
M
 1
 
O
K
F
6
 B
-A
C
M
 2
 
O
K
F
6
 B
-N
A
M
 2
 
O
K
F
6
 B
-N
A
M
 1
 
 O
K
F
6
 C
o
n
tro
l 2
 
O
K
F
6
 C
o
n
tro
l 1 
O
K
F
6
 B
-A
C
M
 3
 
 O
K
F
6
 B
-N
A
M
 3
 
 O
K
F
6
 B
-A
C
M
 1
 
 O
K
F
6
 C
o
n
tro
l 3 
 O
K
F
6
 A
-A
C
M
 2
 
 O
K
F
6
 A
-N
A
M
 2
 
 O
K
F
6
 A
-A
C
M
 3
 
 O
K
F
6
 A
-A
C
M
 1
 
 O
K
F
6
 A
-N
A
M
 3
 
 
G
e
n
e
 ID
 
Sample 
86 
 
the PCA was repeated separately for both OKF6 and DOK samples (following exclusion of 
the two outliers). Analysis of the OKF6 samples shows that they generally cluster into 
three groups; negative control samples, ‘A’-brand samples (both ACM and NAM) and ‘B’-
brand samples (both ACM and NAM), with one outlier (B-ACM replicate 2). The PCA 
analysis and these proposed groupings are shown in Figure 3.7. The clusters exhibited 
following analysis of the DOK samples are much more distinct and follow the same pattern 
as the OKF6 samples (Figure 3.8).  
 
Figure 3.6: Principal Component Analysis of sequenced samples, stratified on the basis of 
cell line. Two outliers are highlighted. 
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Figure 3.7: Chart showing the contribution of sample factors to the explained variance 
observed in the PCA of all samples.  
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Figure 3.8: Principal Component Analysis of sequenced OFK6 samples, stratified on the 
basis of test group. One outlier has been excluded prior to the analysis. 
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Figure 3.9: Principal Component Analysis of sequenced DOK samples, stratified on the 
basis of test group. One outlier has been excluded prior to the analysis. 
 
 
 
Differential gene expression between groups was investigated, stratified on the basis of 
sample cell line (OKF6 and DOK). Firstly, samples were compared on the basis of 
mouthwash brand (negative control vs. ‘A’ brand vs. ‘B’ brand) (Table 3.9). Differentially 
expressed genes were observed in both cell lines, with the DOK samples exhibiting 
greater numbers overall. In both cell lines, the highest number of differentially expressed 
genes was found when comparing the ‘A’ brand samples to the ‘B’ brand samples (OKF6 – 
110 genes, DOK – 6425 genes, p < 0.01; Student’s t-test). Secondly, samples were 
compared on the basis of ethanol content (ACM vs. NAM) (Table 3.10). Within the OKF6 
samples, no differential expression was observed on this basis. However, the DOK 
samples did display differentially expressed genes between the ‘A’ brand samples (A-ACM 
Control 
Control 
A-ACM 
A-NAM 
B-ACM 
B-NAM ‘B’ Brand 
‘A’ Brand 
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vs. A-NAM – 1062 genes, p < 0.01; Student’s t-test) and the ‘B’ brand samples (B-ACM vs. 
B-NAM – 19 genes, p < 0.01; Student’s t-test).  
 
Table 3.9: Number of significantly differentially expressed genes (p < 0.01; Student’s t-
test) between control, ‘A’ brand and ‘B’ brand groups in OKF6 and DOK cells. Number of 
genes with an absolute log fold change greater than 1 (│log10FC│ > 1) are included in 
brackets. 
 OKF6 DOK 
A-Brand B-Brand A-Brand B-Brand 
Control 36 (7) 84 (5) 3639 (541)  1623 (57) 
A-Brand  110 (75)  6452 (2368) 
 
Table 3.10: Number of significantly differentially expressed genes (p < 0.01; Student’s t-
test) between samples exposed to ACMs and NAMs. Comparisons performed within 
individual brands (i.e. A-ACM vs. A-NAM) as well as combined (i.e. A-ACM and B-ACM vs. 
A-NAM and B-NAM). Number of genes with an absolute log fold change greater than 1 
(│log10FC│ > 1) are included in brackets. 
ACM vs. NAM OKF6 DOK 
A-Brand 0 (0) 1062 (121) 
B-Brand 0 (0) 19 (0) 
Combined 0 (0) 589 (133) 
 
Genes that were differentially expressed in more than one comparison were identified and 
plotted in Venn diagrams. Within the OKF6 cell line, samples exposed to ‘A’ brand 
mouthwashes and ‘B’ brand mouthwashes had 84 and 36 genes respectively significantly 
differentially expressed when compared to the control samples. Of these genes, a total of 
3 were common to both groups (a total of 3.57% and 8.33% respectively for the ‘A’ brand 
and ‘B’ brand samples) (Figure 3.9). Within the DOK cell line, samples exposed to ‘A’ 
brand mouthwashes and ‘B’ brand mouthwashes had 3639 and 1623 genes respectively 
significantly differentially expressed when compared to the control samples. Of these 
genes, a total of 651 were common to both groups (a total of 17.89% and 40.11% 
respectively for the ‘A’ brand and ‘B’ brand samples) (Figure 3.10). Lastly, comparison of 
ACM to NAM exposed samples for both brands in the DOK cell line showed 1062 genes 
and 19 genes differentially expressed for ‘A’ brand and ‘B’ brand samples respectively. Of 
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these genes, 9 were found to be common (0.85% and 47.36% for the ‘A’ brand and ‘B’ 
brand ACM vs. NAM comparisons) (Figure 3.11).  
 
Figure 3.10: Venn diagram of differentially expressed genes in comparisons of control, ‘A’ 
brand and ‘B’ brand samples from the OKF6 cell line. The number of genes that were 
found to be differentially expressed in both comparisons is shown in the overlapping 
section. 
  
 
 
Figure 3.11: Venn diagram of differentially expressed genes in comparisons of control, ‘A’ 
brand and ‘B’ brand samples from the DOK cell line. The number of genes that were found 
to be differentially expressed in both comparisons is shown in the overlapping section. 
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Figure 3.12: Venn diagram of differentially expressed genes in comparisons of samples 
from the DOK cell line exposed to alcohol-containing mouthwashes and their non-alcoholic 
counterpart. The number of genes that were found to be differentially expressed in both 
comparisons is shown in the overlapping section. 
 
 
 
In each of the comparisons, the differential expression of genes related to ethanol-
associated genotoxicity (including those associated with the metabolism of ethanol and 
other xenobiotics, DNA damage and repair and cellular proliferation) was examined and 
collated. In the samples originating from the OKF6 cell line, no differentially expressed 
genes of interest were reported. The DOK samples exposed to ‘A’ brand mouthwashes 
demonstrated mixed expression of genes relating to xenobiotic metabolism (increased 
ALDH2 and CYP1A1 but reduced ALDH1B1) and reduced expression of genes promoting 
cellular division and proliferation (MKI67 and CCNB1) when compared to control (Table 
3.11). Similarly, the DOK samples exposed to ‘B’ brand mouthwashes demonstrated 
increased expression of genes relating to xenobiotic metabolism (ALDH2, ALDH1A3 and 
CYP1A1) and increased expression of genes inhibiting cellular proliferation (CDKN1B and 
CDKN1C). However, GADD45A, which is expressed in response to DNA damage and 
inhibits cellular proliferation, was found to be under-expressed (Table 3.12). Comparisons 
of ACMs to NAMs within brands were also performed for the DOK samples. Samples 
exposed to A-ACM displayed reduced expression of CYP1A1 and increased expression of 
genes associated with the response to DNA damage (CDKN1A, GADD45B, TP53INP1, 
BACH1-IT1, ATF3 and DTL) when compared to those exposed to A-NAM. However, while 
these genes are largely antiproliferative, the marker of proliferation Ki-67 was also over-
9 
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expressed (Table 3.13). Lastly, the comparison of B-ACM to B-NAM revealed an over-
expression of DTL (DNA damage related) as the only significantly differentially expressed 
gene of interest (Table 3.14). 
 
Table 3.11: Genes of interest differentially expressed in DOK cells exposed to ‘A’ brand 
mouthwashes (in comparison to negative control). Differences in expression between 
samples are expressed as logarithmic fold change (Log10FC). P-values according to 
Student’s t-test. 
Gene Description Function Log10FC p-value 
ALDH2 Aldehyde dehydrogenase 2 
family  
Main enzyme involved in metabolism 
of acetaldehdye55 
0.6291 2.09 × 10-4 
ALDH1B1 Aldehyde dehydrogenase 1 
family, member B1 
Involved in metabolism of 
acetaldehdye55 
-0.6982 8.11 × 10-7 
CYP1A1 Cytochrome P450, family 1, 
subfamily A, polypeptide 1 
Xenobiotic and drug metabolism, 
activates polycyclic aromatic 
hydrocarbons found in tobacco205 
2.2034 3.76 × 10-18 
MKI67 Ki-67 proliferation marker Protein strongly associated with 
cellular proliferation206 
-2.9751 2.73 × 10-13 
CCNB1 Cyclin B1  Associated with promotion of cell 
division207 
-1.6550 5.64 × 10-10 
 
Table 3.12: Genes of interest differentially expressed in DOK cells exposed to ‘B’ brand 
mouthwashes (in comparison to negative control). Differences in expression between 
samples are expressed as logarithmic fold change (Log10FC). P-values according to 
Student’s t-test. 
Gene Description Function Log10FC p-value 
ALDH2 
Aldehyde dehydrogenase 2 
family  
Main enzyme involved in metabolism 
of acetaldehdye 
0.4714 5.64 × 10-3 
ALDH1A3 
Aldehyde dehydrogenase 1 
family, member A3 
Involved in metabolism of 
acetaldehdye 
0.8858 2.37 × 10-9 
CYP1A1 
Cytochrome P450, family 1, 
subfamily A, polypeptide 1 
Xenobiotic and drug metabolism, 
activates polycyclic aromatic 
hydrocarbons found in tobacco 
1.9297 1.36 × 10-12 
CDKN1C 
Cyclin-dependent kinase 
inhibitor 1C (p57, Kip2) 
Inhibitory regulator of cellular 
proliferation208 
0.9657 2.72 × 10-3 
CDKN1B 
Cyclin-dependent kinase 
inhibitor 1B (p27, Kip1) 
Inhibitory regulator of cellular 
proliferation209 
0.3413 8.96 × 10-3 
GADD45A 
Growth arrest and DNA-
damage-inducible, alpha 
Expressed in response to DNA 
damage, modulates cell cycle210 
-0.4521 6.14 × 10-7 
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Table 3.13: Genes of interest differentially expressed in DOK cells exposed to A-ACM 
compared to those expressed to A-NAM. Differences in expression between samples are 
expressed as logarithmic fold change (Log10FC). P-values according to Student’s t-test. 
Gene Description Function Log10FC p-value 
CYP1A1 
Cytochrome P450, family 1, 
subfamily A, polypeptide 1 
Xenobiotic and drug metabolism, 
activates polycyclic aromatic 
hydrocarbons found in tobacco 
-0.9037 2.34 × 10-10 
MKI67 Ki-67 proliferation marker 
Protein strongly associated with 
cellular proliferation 
2.1887 3.46 × 10-9 
CDKN1A 
Cyclin-dependent kinase 
inhibitor 1A (p21, Cip1) 
Expressed in response to DNA 
damage, associated with p53 
signalling211 
0.2320 6.7 × 10-3 
GADD45B 
Growth arrest and DNA-
damage-inducible, beta 
Expressed in response to DNA 
damage, modulates cell cycle 
0.6058 1.2 × 10-4 
TP53INP1 
Tumor protein p53 
inducible nuclear protein 1  
Antiproliferative protein expressed in 
response to DNA damage211 
0.34 7.04 × 10-5 
BACH1-IT1 BACH1 intronic transcript 1  
Expressed in response to DNA 
damage, involved in DNA repair212 
0.2903 6.13 × 10-3 
ATF3 
Activating transcription 
factor 3  
Regulates response of cell to 
external stress213 
0.4084 1.04 × 10-3 
DTL 
Denticleless E3 ubiquitin 
protein ligase homolog 
(Drosophila) 
Expressed in response to DNA 
damage, acts as checkpoint to 
prevent cell replication214 
2.8476 2.63 × 10-5 
 
Table 3.14: Genes of interest differentially expressed in DOK cells exposed to B-ACM 
compared to those expressed to B-NAM. Differences in expression between samples are 
expressed as logarithmic fold change (Log10FC). P-values according to Student’s t-test. 
Gene Description Function Log10FC p-value 
DTL 
Denticleless E3 ubiquitin 
protein ligase homolog 
(Drosophila) 
Expressed in response to DNA 
damage, acts as checkpoint to 
prevent cell replication 
1.7479 1.11 × 10-3 
 
Pathway enrichment analysis of the most significantly differentially expressed genes for 
each of the comparisons was performed in order to investigate overall transcriptomic 
changes. Examination of the differentially expressed pathways associated with the OKF6 
samples revealed no changes related to any processes of interest (Table 3.15 and Table 
3.16). Comparison of DOK samples exposed to ‘A’ brand mouthwashes and ‘B’ brand 
mouthwashes to control groups primarily showed differential expression in pathways 
associated with cytoskeleton remodelling, the cell cycle, cell adhesion and DNA damage. 
These associations were found to be stronger in the samples exposed to ‘A’ brand 
mouthwashes (Table 3.17 and Table 3.18). Lastly, DOK samples were compared within 
brand on the basis of ethanol content (i.e. A-ACM vs. A-NAM and B-ACM vs. B-NAM). The 
most significantly represented differentially expressed pathways were once again those 
related to cell adhesion, the cell cycle and cytoskeleton remodelling. However, an absence 
of pathways related to DNA damage was also noted (Table 3.19 and Table 3.20).  
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Table 3.15: Top 10 most significant biological pathways associated with differentially 
expressed genes in the comparison of ‘A’ brand mouthwash samples to negative control 
samples in the OKF6 cell line. P-values according to hypergeometric test. 
Category Specific Pathway p-value 
Immune response Alternative complement pathway 5.08 × 10-5 
Regulation of metabolism Bile acids regulation of glucose and lipid metabolism via FXR 2.19 × 10-3 
Neurophysiological process Receptor-mediated axon growth repulsion 3.23 × 10-3 
Signal transduction PTMs in IL-17-induced CIKS-independent signalling 
pathways 
3.38 × 10-3 
Immune response Th17 cells in CF (mouse model) 3.82 × 10-3 
Immune response Th17 cells in CF 4.63 × 10-3 
Development EGFR signalling pathway 7.88 × 10-3 
Reproduction GnRH signalling 8.1 × 10-3 
Development Role of nicotinamide in G-CSF-induced granulopoiesis 2.26 × 10-2 
Regulation of lipid 
metabolism 
Regulation of acetyl-CoA carboxylase 1 activity in 
keratinocytes 
3.19 × 10-2 
 
Table 3.16: Top 10 most significant biological pathways associated with differentially 
expressed genes in the comparison of ‘B’ brand mouthwash samples to negative control 
samples in the OKF6 cell line. P-values according to hypergeometric test. 
Category Specific Pathway p-value 
Development  Non-genomic action of Retinoic acid in cell differentiation 3.52 × 10-5 
Transcription Ligand-dependent activation of the ESR1/SP pathway 1.34 × 10-4 
Development VEGF signalling and activation 3.97 × 10-4 
Development 
Growth factors in regulation of oligodendrocyte precursor cell 
proliferation 
1.46 × 10-3 
General Multiple myeloma 1.64 × 10-3 
Development Leptin signalling via JAK/STAT and MAPK cascades 3.18 × 10-3 
Development 
S1P2 and S1P3 receptors in cell proliferation and 
differentiation 
3.43 × 10-3 
Regulation of lipid 
metabolism 
RXR-dependent regulation of lipid metabolism via PPAR, 
RAR and VDR 
4.56 × 10-3 
Development Osteopontin signalling in osteoclasts 4.56 × 10-3 
Development EGFR signalling via small GTPases 5.5 × 10-3 
 
Table 3.17: Top 10 most significant biological pathways associated with differentially 
expressed genes in the comparison of ‘A’ brand mouthwash samples to negative control 
samples in the DOK cell line. P-values according to hypergeometric test. 
Category Specific Pathway p-value 
Cytoskeleton remodelling Keratin filaments 9.75 × 10-16 
Cell cycle The metaphase checkpoint 1.54 × 10-14 
Cytoskeleton remodelling Cytoskeleton remodelling 2 × 10-14 
Cytoskeleton remodelling TGF, WNT and cytoskeletal remodelling 3.51 × 10-14 
Cell cycle Spindle assembly and chromosome separation 1.57 × 10-13 
Cell cycle Role of APC in cell cycle regulation 8.35 × 10-13 
Cell cycle Regulation of G1/S transition (part 1) 1.29 × 10-13 
Cell cycle Start of DNA replication in early S phase 1.30 × 10-10 
Cell adhesion Chemokines and adhesion 4.67 × 10-10 
DNA damage ATM / ATR regulation of G2 / M checkpoint 1.18 × 10-9 
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Table 3.18: Top 10 most significant biological pathways associated with differentially 
expressed genes in the comparison of ‘B’ brand mouthwash samples to negative control 
samples in the DOK cell line. P-values according to hypergeometric test. 
Category Specific Pathway p-value 
Cell adhesion Chemokines and adhesion 2.10 × 10-9 
Cytoskeleton remodelling TGF, WNT and cytoskeletal remodelling 3.73 × 10-8 
General Colorectal cancer 7.23 × 10-8 
General Neuroprotective action of lithium 1.24 × 10-7 
Immune response Alternative complement pathway 2.56 × 10-7 
Transcription P53 signalling pathway 2.56 × 10-7 
Apoptosis and survival p53-dependent apoptosis 4.87 × 10-7 
DNA damage Brca1 as a transcription regulator 7.27 × 10-7 
Signal transduction AKT signalling 9.21 × 10-7 
DNA damage ATM/ATR regulation of G1/S checkpoint 1.54 × 10-6 
 
Table 3.19: Top 10 most significant biological pathways associated with differentially 
expressed genes in the comparison of A-ACM and A-NAM samples in the DOK cell line. 
P-values according to hypergeometric test. 
Category Specific Pathway p-value 
Cell adhesion Chemokines and adhesion 2.61 × 10-14 
Cytoskeleton remodelling Cytoskeleton remodelling 3.51 × 10-13 
Cytoskeleton remodelling TGF, WNT and cytoskeletal remodelling 4.17 × 10-13 
Development TGF-beta-dependent induction of EMT via MAPK  1.22 × 10-9 
Cell adhesion Integrin-mediated cell adhesion and migration 1.71 × 10-9 
Reproduction GnRH signaling 2.26 × 10-9 
Cell adhesion Role of tetraspanins in the integrin-mediated cell adhesion 4.16 × 10-9 
Cell adhesion ECM remodelling 5.91 × 10-9 
Transcription Role of AP-1 in regulation of cellular metabolism 6.07 × 10-9 
Immune response MIF-induced cell adhesion, migration and angiogenesis 8.85 × 10-9 
 
Table 3.20: Top 10 most significant biological pathways associated with differentially 
expressed genes in the comparison of B-ACM and B-NAM samples in the DOK cell line. 
P-values according to hypergeometric test. 
Category Specific Pathway p-value 
Cell cycle Start of DNA replication in early S phase 2.31 × 10-4 
Cell cycle Role of APC in cell cycle regulation 2.35 × 10-2 
Development Regulation of oligodendrocyte precursor cell differentiation 2.49 × 10-2 
Cytoskeleton remodelling Keratin filaments 2.64 × 10-2 
Development Astrocyte differentiation from adult stem cells 2.93 × 10-2 
Signal transduction CFTR-dependent regulation of ion channels in CF 3 × 10-2 
Development Notch signalling pathway 3.14 × 10-2 
Signal transduction PKA signalling 3.72 × 10-2 
Immune response 
T regulatory cell-mediated modulation of effector T cell and 
NK cell functions 
3.86 × 10-2 
Apoptosis and survival Role of PKR in stress-induced apoptosis 3.86  10-2 
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3.4 Discussion 
 
In this study, we utilised next-generation sequencing technologies to fully investigate 
transcriptomic changes in both normal oral keratinocyte (OKF6) and dysplastic oral 
keratinocyte (DOK) cell lines that were treated in-vitro with repeated exposures of 
solutions of alcohol-containing and non-alcoholic mouthwashes. As this technology has 
never been applied to the investigation of the effects of mouthwash exposure, a pilot study 
to determine the viability of this method was designed and executed. Initial quality control 
tests of the sequencing pilot data revealed that all libraries had both a high average quality 
score (approximate Phred score of 24) and a large proportion of reads mapping to the 
human reference genome (an average of approximately 93%). Several important points 
were extrapolated from the analysis of the pilot data. Firstly, the quality metrics (i.e. the 
quality of the individual reads and overall transcriptome data) indicated that a progression 
to more in-depth analysis was possible. Secondly, analysis of total gene expression 
revealed that a broad split within the samples on the basis of whether they originated from 
the OKF6 or DOK cell line. This factor that had the greatest influence when grouping 
samples, followed secondarily by the day on which the samples were harvested (i.e. Day 0 
vs. Day 7). The difference on the basis of culture date was likely due to contact inhibition, 
which occurs during over-confluence in cell culture.215 Lastly, after removing both cell line 
type and culture time as applicable factors, the samples clustered very tightly together with 
regards to gene expression. The data therefore lacked the statistical power to allow the 
identification of any differences between mouthwash brands and between alcohol-
containing and non-alcoholic mouthwashes. These findings were taken into account when 
redesigning the experiment in order to achieve the aims of the study. While the exposure 
protocol remained unchanged, the number of biological replicates for each test and control 
group was increased from one to three in order to increase the statistical power and allow 
discrimination between samples based around a common cell line. Analysis of the results 
following this redesign revealed that it had the desired effect, greatly increasing the 
number of significantly differentially expressed genes that were detected in comparisons 
between samples.  
 
The primary aim of this study was to use RNA-Seq data to investigate transcriptomic 
changes brought about in oral keratinocytes by repeated ACM and NAM exposure 
(particularly in gene pathways associated with ethanol-related genotoxicity), with a 
secondary focus on how these responses differed between normal and dysplastic tissues. 
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Following the execution of the experiment in accordance with these aims, a number of 
results were observed overall. Significant transcriptomic changes in response to repeated 
exposures over an extended time period (in comparison to a control group) were observed 
in samples from both cell lines and in response to mouthwashes from both brands. This 
indicates that mouthwash exposure, from either ACMs or NAMs, does indeed influence 
local gene expression in oral keratinocytes. In the OKF6 samples, a greater number of 
differentially expressed genes were observed in response to exposure to the ‘B’ brand 
mouthwashes. However, the opposite occurred in the DOK samples, with the ‘A’ brand 
exposed samples showing greater differential expression. When samples were stratified 
on the basis of ethanol exposure (ACM vs. NAM), no differentially expressed genes were 
observed in the OKF6 samples (as in the pilot data). However, differentially expressed 
genes were observed for both brands in the DOK samples. Analysis of the differential 
expression of genes associated with the metabolism of ethanol and other xenobiotics, 
DNA damage and repair and cellular proliferation was also performed within the ACM vs. 
NAM comparisons of the DOK samples. While genes relating to the metabolism of ethanol 
(CYP2E1, ADH1B and ALDH2) were unchanged, genes expressed in response to DNA 
damage and those related to DNA repair and halting proliferation were over-expressed in 
both the A-ACM and B-ACM samples. Pathway enrichment analysis of the differentially 
expressed genes for each comparison revealed no emphasis on any pathways of 
relevance for the samples derived from the OKF6 cell line. Conversely, analysis of DOK 
samples revealed differential expression in pathways associated with cytoskeleton 
remodelling, the cell cycle and cell adhesion. Overall, significant transcriptomic changes 
were found to have occurred in response to exposure to ACMs and NAMs. However, the 
magnitude and content of these changes differed according to both cell line origin and 
ethanol content. These points in particular are discussed in further detail below. 
 
As discussed previously, the presence of ethanol in mouthwashes has been a cause for 
concern in the past, given its status as a recognised carcinogen implicated in the 
development of OSCC.14 Ethanol indirectly causes DNA damage through a number of 
established mechanisms, such as the generation of acetaldehyde, up-regulation of 
CYP2E1 and the generation of mutagenic reactive oxygen species and lipid peroxides.41-
43, 68-70, 82, 83, 89-91, 97, 99 One of the main aims of this study was to determine whether 
transcriptomic changes that occurred in response to repeated exposure to ACMs differed 
from those in response to NAM exposure, particularly in the pathways associated with 
ethanol-induced genotoxicity. To investigate this, intra-brand comparisons were performed 
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within cell lines on the basis of ethanol content (A-ACM vs. A-NAM and B-ACM vs. B-
NAM). Comparison of the OKF6 samples revealed no differentially expressed genes 
between ACMs and NAMs for either brand. However, the same comparison with the DOK 
samples revealed 1062 significantly differentially expressed genes within the ‘A’ brand 
exposed samples and 19 significantly differentially expressed genes within the ‘B’ brand 
exposed samples. Of these, 9 were differentially expressed in both comparisons. Several 
points can be extrapolated from this result. Firstly, differential gene expression in response 
to the inclusion of ethanol differed significantly between the two cell lines tested, as 
evidenced by the OKF6 samples reporting no differentially expressed genes. This result 
was consistent with the overall trend of significant differences between the transcriptomic 
responses of the normal and dysplastic cell lines (a relationship that is explored in greater 
detail below). Secondly, analysis of the DOK samples revealed approximately 50-fold 
more genes were differentially expressed within the ‘A’ brand comparison compared to the 
‘B’ brand comparison. This is also reflected within the Principal Components Analysis, 
where B-ACM and B-NAM samples are observed to cluster closer together (indicating 
similarity) than their ‘A’ brand counterparts. Thirdly, of the 9 genes significantly 
differentially expressed in both comparisons, only a single gene, DTL (Denticleless E3 
Ubiquitin Protein Ligase Homolog), was relevant to ethanol-related genotoxicity. DTL, also 
known as CDT2, is a protein that acts as a substrate specific adaptor for the CRL4 
Ubiquitin E3 Ligase complex formed by UV-damaged DNA Binding Protein 1 (DDB1), 
Cullin 4 (CUL4) and Ring Box 1 (RBX1). The presence of DTL allows CRL4 to degrade 
CDT1, a cell cycle regulator that is integral to the initiation of DNA replication. DTL is up-
regulated in response to DNA damage, where it acts through CRL4 to degrade CDT1 and 
thus prevent cellular replication and maintain genomic stability.216, 217 DTL and CRL4 have 
also been found to modulate the activity of DNA polymerase δ in response to DNA 
damage.218 In both ‘A’ brand and ‘B’ brand comparisons within the DOK cell line samples, 
DTL was over-expressed in response to ACM exposures (A-ACM Log10FC = 2.8476 and 
B-ACM Log10FC = 0.9642) compared to NAM exposures, indicating greater up-regulation 
of this product as a result of DNA damage. Overexpression of this gene in response to 
ethanol exposure is important as it can indicate increased activity associated with the 
intracellular pathways responsible for minimising the long term genomic effects of DNA 
damage. Any malfunction of this pathway results in a loss of this protection and the 
persistence of DNA errors through replication (with the eventual possibility of 
carcinogenesis). Lastly, in both normal and dysplastic cell lines a greater number of 
differentially expressed genes were observed in the normal vs. exposed comparisons (i.e. 
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‘A’ brand vs. control and ‘B’ brand vs. control) than the comparisons on the basis of 
ethanol (i.e. A-ACM vs. A-NAM and B-ACM vs. B-NAM). This would appear to indicate that 
the transcriptome undergoes greater change in response to the insult of the mouthwash 
exposure, rather than in response to the presence of ethanol within the mouthwash 
formulation. Evaluation of the PCA for each cell line also reveals that samples tend to 
group more on the basis of the brand they were exposed to (as opposed to on the basis of 
ethanol content). Overall, analysis of differential expression on the basis of ethanol content 
revealed that while its presence in ACMs appears to have only a minor role in inducing 
transcriptomic changes (when compared to mouthwash brand), it has a greater effect in a 
dysplastic cell line, including over-expression of a gene related to the DNA damage 
pathway.  
 
Another of the main aims of this study was to determine whether normal and dysplastic 
oral tissues are affected differently in response to repeated exposures to mouthwash. Oral 
epithelial dysplasia (OED) refers to architectural and cellular changes brought about by 
dysregulation on the genomic level. This can be incorporated into the theory of field 
cancerisation, where OED signifies an area of the mucosal surface that has acquired a 
combination of mutations promoting a shift towards a neoplastic phenotype. The presence 
of existing progression and an increasingly dysregulated cellular response to genotoxic 
insult both contribute towards a higher risk of malignant transformation within this area. As 
explained previously, field cancerisation in the oral cavity is driven primarily by 
environmental exposures such as tobacco, alcohol and betel nut. While exposure to 
mouthwashes (ACMs in particular) remains a debated risk factor with regards to OSCC, it 
does present the potential for genotoxic insult (especially in a pre-sensitised mucosal 
field). Thus it is of interest how oral tissues with a partial progression to malignancy 
respond to exposure to ACMs and NAMs, particularly in comparison to normal oral 
mucosa. To investigate this, both normal and dysplastic oral keratinocyte cell lines were 
included and their transcriptomes sequenced. On analysis, several findings were noted 
when comparing the two cell lines. Firstly, an overall greater response in differential 
expression was noted in the DOK samples in response to mouthwash exposure when 
compared to the OKF6 samples. Principal Component Analysis showed distinct groupings 
on the basis of exposure within the DOK samples, while within the OKF6 samples the 
groupings were much less defined (indicating greater similarities between exposure 
groups with regards to mRNA expression). A higher number of differentially expressed 
genes was also observed within the comparisons of the DOK samples when compared to 
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the OKF6 sample comparisons. For example, in comparison to control samples, treatment 
with ‘A’ brand and ‘B’ brand mouthwashes resulted in 36 and 84 significantly differentially 
expressed genes respectively in the OKF6 samples. However, the same treatments when 
applied to the DOK samples resulted in 3639 and 1623 significantly differentially 
expressed genes. This trend also carried over to the intra-brand comparison of 
differentially expressed genes between ACM and NAM exposed samples. In comparisons 
on the basis of ethanol content (A-ACM vs. A-NAM and B-ACM vs. B-NAM), no 
significantly differentially expressed genes were noted in the OKF6 samples while in the 
DOK samples both brands reported differentially expressed genes. Overall these results 
indicate that the transcriptomic response of the DOK cell line to mouthwash exposure was 
greater in both variety and magnitude when compared to the normal OKF6 cell line. 
Secondly, more genes of interest related to ethanol metabolism, cellular proliferation and 
the DNA damage response were differentially expressed in DOK-derived samples. In 
comparisons to control groups, increased expression of xenobiotic metabolism enzymes, 
reduced expression of cellular proliferation markers and increased expression of cell cycle 
regulators were observed in response to exposure to both ‘A’ brand and ‘B’ brand 
mouthwashes. Of note is the up-regulation of the cyclin-dependent kinase inhibitors p57 
and p27 in mouthwash exposed DOK samples, both of which act to prevent cell replication 
and have been found to be up-regulated in response to DNA damage.219, 220 Intra-brand 
comparisons on the basis of ethanol also showed increased expression of DNA damage 
related anti-proliferative products in samples exposed to ACMs. Pathway analysis of DOK 
samples also revealed greater differential expression in pathways related to the cell cycle, 
cytoskeleton remodelling, cell motility and the DNA damage response. On the other hand, 
no genes of interest were found to be differentially expressed nor any relevant pathways 
identified when the OKF6 samples were analysed. Overall, the inclusion of dysplastic oral 
keratinocytes in the study revealed that they undergo greater transcriptomic changes in 
response to repeated exposures to ACM and NAM solutions than their normal 
counterparts, particularly in areas related to ethanol-induced genotoxicity. These findings 
have strong clinical implications. It has been postulated previously that alcohol-containing 
mouthwash use in patients with oral epithelial dysplasia should be of a concern given the 
repeated exposure of ethanol to an already sensitised mucosal field.166 These results 
would appear to support that assertion, as not only was a stronger overall transcriptomic 
change observed in dysplastic cells (when compared to normal cells)but also activity of 
genes relating to DNA damage, DNA repair and cell cycle regulation.  
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This study has a number of limitations that can be identified. Firstly, the use of an in-vitro 
cultured oral keratinocyte monolayer as a model for exposure presents several problems, 
as discussed in the previous chapter. Drawbacks include a lack of typical mucosal 
structure (multiple layers, lamina propria, blood supply etc.), a reduced toxicity threshold 
and a limited maintainability. These factors limit the dosage, time and frequency of 
exposures and reduce the clinical relevance of the results. The maintenance of a cellular 
monolayer at 100% confluence also does not represent an ideal model given the lack of 
constant cellular turnover characteristic to native tissue. Secondly, both the range of 
variables tested and the sample size of this study were limited due to the cost, time and 
manpower required for next generation sequencing. The investigation was also limited by 
the amount of bioinformatics support available given the sheer amount of data generated 
by next generation sequencing. Lastly, the results of this study, particularly relating to the 
effects of the inclusion of ethanol on differential gene expression, have highlighted the 
requirement for sequencing depth as well as breadth. This is evidenced by the shift after 
the pilot study from a single biological replicate to three biological replicates per test group, 
which revealed significantly differentially expressed genes that had not been previously 
detected. While it is constrained by the previously mentioned limitations, depth with 
regards to biological replicates is important when using next generation sequencing to 
discern transcriptomic changes in response to exposures with limited biological impacts 
(such as the comparison on the basis of ethanol content performed in this study). These 
limitations are addressed below along with recommendations for future directions. 
 
There are a number of future directions that can be advised based on the findings of this 
study. Firstly, the greater transcriptomic changes observed in dysplastic oral keratinocytes 
in response to repeated mouthwash exposure (compared to normal oral keratinocytes) 
warrants further investigation. As mentioned previously, areas of oral epithelial dysplasia 
are a concern due to their dysregulated nature and increased potential for malignant 
transformation. Studies relating to the effects of alcohol-containing mouthwash with 
regards to oral epithelial dysplasia are essentially non-existent, with only several 
epidemiological studies investigating the association between the two from a development 
perspective (as opposed to investigating how the presence of dysplasia affects how ACMs 
interact with oral mucosa).221, 222 Further in-vitro or in-vivo research is required to 
determine exactly how areas of dysplasia respond to mouthwash exposure, particularly 
those containing ethanol as part of their formulation. Secondly, to compensate for the 
weaknesses in the current cell culture model, an alternative model to investigate the 
103 
 
effects of prolonged repeated mouthwash exposures should be explored. This could take 
the form of an in-vivo study utilising oral mucosal swabs or biopsies from human 
volunteers as samples to be sequenced (though any study involving human participants 
requires extensive planning to satisfy ethical requirements). This would also address some 
of the limitations regarding clinical relevance. Alternative in-vitro biological models with the 
ability to withstand stronger and more repeated doses were also discussed in the previous 
chapter. The use of a dynamic substrate such as an animal model would compensate for 
the lack of native cellular turnover in the current monolayer model. Lastly, further research 
involving investigating transcriptomic changes should incorporate greater numbers of 
samples to allow greater detection of significantly differentially expressed genes. While this 
is currently constrained by the costs of sequencing, it continues to become more 
affordable over time.223 
 
3.5 Conclusion 
 
In conclusion, this study was successful in achieving its stated aim of investigating 
transcriptomic change in normal and dysplastic oral keratinocytes subjected to repeated 
exposures to alcohol-containing and non-alcoholic mouthwashes. Samples derived from a 
dysplastic cell line were found to undergo changes of a greater range and magnitude than 
those from a normal cell line. Dysplastic samples also showed largely increased activity in 
genes associated with xenobiotic metabolism, cell cycle regulation and the DNA damage 
response. Comparisons of ACM and NAM exposed groups revealed that the inclusion of 
ethanol in mouthwash formulations had only a minor impact with regards to inducing 
differential gene expression. However, one of the genes found to be consistently over-
expressed following ACM exposure is strongly linked to DNA damage response and cell 
cycle arrest. Overall, the effect of repeated mouthwash exposures (particularly those 
containing ethanol) on patients with oral epithelial dysplasia represents an important 
candidate for future research. 
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4.1 Oral squamous cell carcinoma and current research 
 
Oral squamous cell carcinoma (OSCC) continues to represent a significant health burden 
in Australia, with a reported incidence of 3123 cases nationwide in 2009.224 As an 
aggressive malignancy, OSCC usually progresses to an advanced state before detection 
and treatment. The unfortunate outcomes of late detection are a poor 5 year survival rate 
(due to aggressive lymphatic spread) and significant decreases in health-related quality of 
life, even after treatment.3, 225 As a result, there is a significant research focus on both the 
prevention and early detection of OSCC, with the aim of minimising the mortality and 
personal costs associated with late-stage detection and treatment.226-228 Prevention of 
malignancy involves understanding both the pathophysiological nature of the disease and 
also its causes. OSCC develops as a result of the stepwise accumulation of undesirable 
genetic alterations in oral keratinocytes (particularly proliferative basal cells), leading to the 
development of a malignant phenotype.1 As such, a significant body of research has 
developed around the use of next-generation sequencing to investigate these genetic 
changes.229 The major factors that are thus far recognised as driving this carcinogenic 
process are the environmental exposures of tobacco, alcohol and betel nut.2 With regards 
to prevention, a greater understanding of how these environmental agents initiate and 
drive carcinogenesis is paramount. This study has chosen to focus on alcohol-containing 
mouthwashes (ACMs) and their role as a possible risk factor. The relationship of ACMs to 
the development of OSCC remains controversial, with inconsistent epidemiological 
findings. Both in-vitro and in-vivo studies are also limited, particularly with regards to their 
scope.166 Thus this study attempted to thoroughly investigate the changes induced 
following exposure to ACMs in oral keratinocytes on both a cellular and genetic level, 
particularly from the perspective of ethanol-related oral carcinogenesis.  
 
4.2 Cellular and transcriptomic effects of alcohol-containing mouthwash exposure 
 
As far as the authors are aware, this is the first study to investigate the cellular effects of 
alcohol-containing mouthwash and non-alcoholic mouthwash exposure following repeated 
short exposures (as opposed to a single acute exposure). It is also the first study to utilise 
next-generation sequencing as a technique to investigate these changes. Several primary 
findings were observed during this study. The addition of ethanol to mouthwash 
formulations was found to significantly increase DNA strand breaks following an acute 
exposure in both normal and dysplastic oral keratinocytes. However, neither CYP2E1 
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induction nor lipid peroxidation were found to be increased by ACM exposure (compared 
to NAMs), suggesting against the involvement of an oxidative pathway in ethanol-related 
genotoxicity. Repeated exposure to ACMs and NAMs was also found to induce 
transcriptomic changes in both normal and dysplastic oral keratinocytes. Greater changes 
were noted in dysplastic samples, particularly in genes associated with xenobiotic 
metabolism, cell cycle regulation and the DNA damage response. The inclusion of ethanol 
in mouthwash formulations was also found to cause up-regulation of DTL, a gene strongly 
associated with the DNA damage response and cell cycle arrest, in dysplastic samples. 
However, as a variable, the presence of ethanol was found to have less of an influence on 
transcriptomic response than the brand of mouthwash. Overall, while ethanol contained in 
mouthwashes does appear to exert genotoxic effects, the exact mechanism through which 
this occurs remains partly elusive. Dysplastic oral keratinocytes also appear to be more 
sensitive to mouthwash exposure, exhibiting both higher levels of DNA damage and a 
greater range of transcriptomic changes. 
 
4.3 Ethanol in mouthwashes 
 
In the past, objections have been raised with regards to the use of alcohol-containing 
mouthwashes as a result of concerns relating to the inclusion of significant concentrations 
of ethanol within their formulations (exposure to ethanol being a recognised risk factor in 
the development of OSCC).131 While the literature does lack a united opinion, several 
authors have questioned the need for the addition of ethanol or have outright 
recommended against the use of ACMs in order to eliminate any potential increase in 
OSCC risk.108, 131, 132, 166 As previously discussed, the addition of ethanol to mouthwashes 
was found to have a number of effects following exposure to normal and dysplastic oral 
keratinocytes. These included a significant increase in DNA strand breaks following an 
acute exposure in both cell lines and the significant up-regulation of a DNA damage 
induced gene, DTL, in dysplastic cells following repeated exposures. While these 
observations are only drawn from an in-vitro mechanistic study, the results observed do 
suggest that ethanol present in mouthwashes plays a role in triggering adverse changes in 
oral keratinocytes, particularly those that are dysplastic. As a result, there are a number of 
implications that can be deduced from the findings of this study. Firstly, it is clear that 
further investigation, particularly relating to ethanol-related genotoxic mechanisms in oral 
keratinocytes, is required to produce a more complete picture as to the effects of ACM 
exposure. Secondly, the evidence of an ethanol-related genotoxic mechanism in oral 
108 
 
keratinocytes should promote renewed discussion about the suitability of the inclusion of 
ethanol in mouthwash formulations. This is particularly relevant for patients with areas of 
dysplastic mucosa in the oral cavity, as additional undesirable changes were observed in 
dysplastic cell models. This is discussed in greater depth in the proceeding paragraphs. 
 
4.4 Alcohol-containing mouthwashes and patient risk groups 
 
From a clinical perspective, several groups of patients could theoretically be at higher risk 
of adverse cellular changes with chronic use of alcohol-containing mouthwash. Firstly, 
subjects who smoke and use alcohol-containing mouthwash are regularly exposed to both 
tobacco carcinogens and ethanol. As mentioned previously, concurrent exposure to these 
two environmental factors produces a greater than multiplicative increase in OSCC risk 
compared to either alone. 5, 8-10, 12, 21, 25, 30, 40, 41 This is likely due to both increased CYP2E1 
enzyme activity leading to activation of tobacco pro-carcinogens and ethanol-induced 
permeability of the oral mucosa. In this study, both CYP2E1 gene expression and activity 
were measured in cultured oral keratinocytes following repeated exposures over the period 
of a week. While no particular increase in activity was noted in this case, expression of the 
CYP2E1 enzyme has been observed in past studies in primary oral epithelial samples.72-75 
Also noted during this study was overexpression of the enzyme CYP1A1 in DOK samples 
in response to repeated mouthwash exposures. CYP1A1, expression of which has 
previously been observed in oral keratinocytes, interacts with certain pro-carcinogens 
found in tobacco smoke (including a range of polycyclic aromatic hydrocarbons) and has 
the effect of activating them to their carcinogenic form.72, 205 Interestingly, CYP1A1 has 
also been found to be overexpressed in the oral mucosa of smokers, where it is induced 
by hydrocarbon exposure.230 Epidemiological studies have also shown that current and 
past smokers are more likely to use mouthwash.112, 113, 115, 116, 126 Secondly, use of alcohol-
containing mouthwash by patients with oral epithelial dysplasia has the potential for 
concern, as continued exposure to ethanol may act to facilitate progression towards 
malignancy.  Patients with oral epithelial dysplasia tend to be smokers, and the oral 
epithelium in these patients is already transformed, placing them at heightened risk of 
further cellular and molecular damage should they engage in chronic use of alcohol-
containing mouthwash.222 It is also possible that the discovery of an oral lesion by a patient 
may act as the motivating factor for mouthwash use, which would place the patient at 
increased risk of further damage to an existent lesion. In this study it was revealed that in 
response to repeated mouthwash exposures, dysplastic oral keratinocytes undergo 
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greater transcriptomic changes than normal keratinocytes, particularly in pathways related 
to cell cycle control and DNA damage. This increase in sensitivity to external influence is 
of concern, especially if it extends to other environmental agents. The authors of this study 
maintain their previous recommendation that it is the responsibility of clinicians to educate 
patients about the presence of ethanol in mouthwashes in order to minimise any possible 
risks brought about by their usage, particularly in those patients who belong to a group 
with the potential for increased risk.166 It is also important to once again note that the 
addition of ethanol to mouthwashes is of questionable validity at this time, given that non-
alcoholic mouthwashes (widely available on the market) have been shown to be just as 
effective as ACMs and to have a reduced incidence of adverse effects.154-161  
 
4.5 Future directions and recommendations 
 
As mentioned previously, further investigation is required in the future in order to gain a 
more complete understanding of the changes induced in oral keratinocytes and oral 
mucosa by exposure to alcohol-containing mouthwashes. Using the experiences of this 
study, there are a number of suggestions that can be made regarding the direction of this 
research. Firstly, an expansion of the research scope to include alternate genotoxic 
pathways and other cellular events relating to ethanol exposure is strongly advised. The 
current study primarily focused on the production and effects of oxidative stress, the 
effects on gene expression and the induction of DNA damage following alcohol-containing 
and non-alcoholic mouthwash exposure. However, these changes only reflect part of the 
complex cellular events and responses. Possible broad targets for future research include 
the production pathway of acetaldehyde and its associated effects, DNA repair 
mechanisms and mutagenic DNA adducts. Secondly, a feasibility study should be 
conducted regarding the use of animal models to investigate the effects of mouthwash 
exposure. As explained earlier in this thesis, the use of animal models has a number of 
advantages over cell culture models for several reasons, primarily due to a superior 
durability over time (for longer duration, more repeated or higher dose exposures) and a 
greater applicability of the results to an actual human patient. In the past, animal models 
have been used to investigate the effects of long-term repeated alcohol exposure on the 
oral and eosphageal mucosa, but not mouthwash exposure as of yet.147-149 This study also 
demonstrated the feasibility of using next-generation sequencing techniques to investigate 
transcriptomic changes in cultured oral keratinocytes, which remains an avenue for future 
research.  
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4.6 Final conclusions 
 
While the inclusion of ethanol in mouthwashes does appear to induce a number of 
undesirable changes in oral cells, the causes and long term significance of these changes 
are still not fully understood. The accumulation of previous genetic damage and 
undesirable mutations also appears to play an important role in how oral cells are affected 
by exposure to mouthwash. Further in-vitro and in-vivo investigations using novel 
biological models are required to investigate the contribution of other cellular pathways to 
ethanol-related genotoxicity following mouthwash exposures. It is also advisable that 
additional properly designed epidemiological studies are performed, with a particular focus 
on how existing dysplasia modifies potential risk. Despite the current absence of 
conclusive evidence regarding the potential effects of long term alcohol-containing 
mouthwash exposure, it is still recommended that clinicians effectively educate their 
patients about the presence of ethanol in mouthwashes in order to minimise any possible 
increases in risk. 
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In order to determine an acceptable test exposure for the study, a toxicity study was 
performed in 96-well plates. Two exposure regimens were trialled; a one-time exposure of 
5 minutes (an acute exposure) and repeated exposures twice daily for 10 minutes for 1 
week total (a chronic exposure). For testing acute exposures, each of the mouthwash test 
groups was diluted in L-Glutamine negative RPMI medium to final concentrations of 5%, 
2.5%, 1% and 0.5%. Following removal of media from the wells, 100 µL of each of the test 
groups was introduced and left to incubate at 37°C for 5 min (a standard ‘acute exposure’ 
for this study). At the end of the exposure, the wells were gently washed with RPMI media 
before being replaced with KSFM. The plates were then incubated at 37°C. After 24 hours 
of incubation, the media was replaced with 1 mg/mL Thiazolyl Blue Tetrazolum Bromide 
RPMI media and incubated at 37°C for 45 min. The wells were irrigated with acidified 
isopropanol and the plates analysed for absorbance in a Paradigm Detection Platform 
(Beckman Coulter, Brea, USA) at 550 nm – 630 nm. Testing chronic exposures was done 
in an identical fashion, except exposures were performed twice daily for 10 minutes for 1 
week total and confluence over time was measured using an Incucyte™ kinetic imager 
(Essen BioScience, Ann Arbor, USA). Results of these assays are shown in Figures I – V.  
 
Figure I: Percentage survival of OKF6 cells at 24 hrs following a 5 min exposure to 
solutions of A-ACM, A-NAM, B-ACM and B-NAM with concentrations varying from 5% to 
0.5% (compared to a negative control). Test groups are unaltered (Original). 
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Figure II: Percentage survival of OKF6 cells at 24 hrs following a 5 min exposure to 
solutions of A-ACM, A-NAM, B-ACM and B-NAM with concentrations varying from 5% to 
0.5% (compared to a negative control). Test groups have had volatiles removed via rotary 
evaporation and have been reconstituted with water (Water). 
 
 
Figure III: Percentage survival of OKF6 cells at 24 hrs following a 5 min exposure to 
solutions of A-ACM, A-NAM, B-ACM and B-NAM with concentrations varying from 5% to 
0.5% (compared to a negative control). Test groups have had volatiles removed via rotary 
evaporation and have been reconstituted with ethanol (Ethanol). 
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Figure IV: Confluence over time of OKF6 cells exposed for 10 min twice daily to a 1% 
solution of either A-ACM, A-NAM, B-ACM or B-NAM or a negative control (plain RPMI).  
 
 
Figure V: Confluence over time of OKF6 cells exposed for 10 min twice daily to a 0.5% 
solution of either A-ACM, A-NAM, B-ACM or B-NAM or a negative control (plain RPMI).  
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